UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


———————

FORM 10-Q

———————


(Mark One)


þ    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended March 31, 2018


or


¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from________ to ________


Commission File Number 001-37916

———————

[SRAX_10Q001.JPG]

SOCIAL REALITY, INC.

(Exact name of registrant as specified in its charter)

———————


Delaware

45-2925231

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

456 Seaton Street, Los Angeles, CA

90013

(Address of principal executive offices)

(Zip Code)


(323) 694-9800

(Registrant’s telephone number, including area code)


Not Applicable

(Former name, former address and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES  þ   NO  ¨


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES  þ   NO  ¨


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer   ¨

 

Accelerated filer    ¨

Non-accelerated filer   ¨

 

Smaller reporting company   þ

 

 

Emerging growth company   ¨


If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES  ¨   NO  þ


Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. 10,212,738 shares of Class A common stock are issued and outstanding as of May 15, 2018.

 

 

 




 


TABLE OF CONTENTS


 

 

Page

 

 

No

 

 

 

 

PART I-FINANCIAL INFORMATION

 

 

 

 

ITEM 1.

Financial Statements .

1

 

 

 

ITEM 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations .

32

 

 

 

ITEM 3.

Quantitative and Qualitative Disclosures About Market Risk .

36

 

 

 

ITEM 4.

Controls and Procedures .

36

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

ITEM 1.

Legal Proceedings .

37

 

 

 

ITEM 1A.

Risk Factors .

37

 

 

 

ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds .

39

 

 

 

ITEM 3.

Defaults Upon Senior Securities .

40

 

 

 

ITEM 4.

Mine Safety Disclosures .

40

 

 

 

ITEM 5.

Other Information .

40

 

 

 

ITEM 6.

Exhibits .

40

 



i



 


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION


This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs. Forward-looking statements include, but are not limited to, statements about:


 

·

our history of losses;

 

·

our ability to continue as a going concern;

 

·

the obligation under senior secured convertible debentures in the principal amount of $6,845,157and compliance with the terms and conditions of these obligations;

 

·

our reliance on third party vendors;

 

·

our dependence on revenues from a limited number of customers;

 

·

our ability to maintain our technology platforms and expand our product offerings;

 

·

our ability to manage our relationships with our publishers;

 

·

risks associated with loss to access to the Facebook, Inc. platform;

 

·

risks associated with loss of access to real time bidding inventory buyers and RTB platforms;

 

·

our dependence on our executive officers;

 

·

the continued appeal of Internet advertising;

 

·

risks related to possible future acquisitions;

 

·

the possible ratchet adjustments of Series A warrants in our January 2017 financing and the Debenture Warrants issued in the April 2017 and October 2017 financing transactions;

 

·

the limited market for our Class A common stock;

 

·

risks associated with securities litigation;

 

·

our failure to meet financial performance guidance;

 

·

risks associated with material weaknesses in our internal control over financial reporting;

 

·

anti-takeover provisions of Delaware law;

 

·

the possible issuance of shares of our Class B common stock;

 

·

limited, inaccurate or unfavorable research about us or our business by securities or industry analysts;

 

·

concentration of ownership by our management;

 

·

dilution to our stockholders from the exercise of outstanding options and warrants, including those with cashless features; and

 

·

the terms of indemnification agreements with our executive officers and directors.


Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements and readers should carefully review this report in its entirety, including the risks described in Part I, Item 1A. - Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on April 2, 2018 and as amended on Form 10K/A on April 27, 2018 as well as other filings with the Securities and Exchange Commission (the “SEC”). Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.


OTHER PERTINENT INFORMATION


When used in this report, the terms “Social Reality,” refers to Social Reality, Inc., a Delaware corporation, and our subsidiary BigToken, Inc., a Delaware corporation which we refer to as "BigToken," (collectively, “we,” “us,” “our” or “the Company”). In addition, the "first quarter of 2018" refers to the three months ended March 31, 2018, the "first quarter of 2017" refers to the three months ended March 31, 2017, “2018” refers to the year ending December 31, 2018, and "2017” refers to the year ended December 31, 2017.


All share and per share information contained in this report gives retroactive effect to the 1:5 reverse stock split of our Class A common stock in September 2016.


The information which appears on our web sites www.srax.com, www.sraxmd.com, and www.bigtoken.com are not part of this report and are specifically not incorporated by reference.




ii



 


PART 1 - FINANCIAL INFORMATION


ITEM 1.

FINANCIAL STATEMENTS.


SOCIAL REALITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS


 

 

March 31,

 

 

December 31,

 

 

 

2018

 

 

2017

 

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

Current assets :

 

 

 

 

 

 

Cash and cash equivalents

 

$

189,888

 

 

$

1,017,299

 

Accounts receivable, net

 

 

1,734,058

 

 

 

4,348,305

 

Prepaid expenses

 

 

540,753

 

 

 

468,336

 

Other current assets

 

 

300,898

 

 

 

300,898

 

Total current assets

 

 

2,765,597

 

 

 

6,134,838

 

 

 

 

 

 

 

 

 

 

Property and equipment, net of accumulated depreciation

 

 

165,898

 

 

 

154,546

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

15,644,957

 

 

 

15,644,957

 

Intangibles - net

 

 

1,708,349

 

 

 

1,642,760

 

Other assets

 

 

32,043

 

 

 

28,598

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

20,316,844

 

 

$

23,605,699

 

 

 

 

 

 

 

 

 

 

Liabilities and stockholders' equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities :

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

4,682,794

 

 

$

5,010,815

 

Total current liabilities

 

 

4,682,794

 

 

 

5,010,815

 

 

 

 

 

 

 

 

 

 

Secured convertible debentures, net

 

 

2,043,804

 

 

 

1,711,146

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

6,726,598

 

 

 

6,721,961

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 13)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2018 and December 31, 2017, respectively

 

 

 

 

 

 

Class A common stock, authorized 250,000,000 shares, $0.001 par value, 10,212,738 and 9,910,565 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively

 

 

10,213

 

 

 

9,911

 

Class B common stock, authorized 9,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2018 and December 31, 2017, respectively

 

 

 

 

 

 

Common stock to be issued

 

 

10,000

 

 

 

879,500

 

Additional paid in capital

 

 

38,328,359

 

 

 

37,143,033

 

Accumulated deficit

 

 

(24,758,326

)

 

 

(21,148,706

)

Total stockholders' equity

 

 

13,590,246

 

 

 

16,883,738

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

$

20,316,844

 

 

$

23,605,699

 



See accompanying footnotes to these unaudited condensed consolidated financial statements.




1



 


SOCIAL REALITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

THREE MONTHS ENDED MARCH 31, 2018 AND 2017

(Unaudited)


 

 

Three Months ended

March 31,

 

 

 

2018

 

 

2017

 

Revenues

 

$

2,110,850

 

 

$

5,326,163

 

Cost of revenue

 

 

818,105

 

 

 

3,279,120

 

Gross profit

 

 

1,292,745

 

 

 

2,047,043

 

 

 

 

 

 

 

 

 

 

Operating expense

 

 

 

 

 

 

 

 

General, selling and administrative expense

 

 

4,130,258

 

 

 

4,409,807

 

Write-off of non-compete agreement

 

 

 

 

 

468,751

 

Restructuring costs

 

 

 

 

 

377,961

 

Total operating expense, net

 

 

4,130,258

 

 

 

5,256,519

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(2,837,513

)

 

 

(3,209,476

)

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

Interest income (expense)

 

 

(434,785

)

 

 

(133,306

)

Amortization of debt issuance costs

 

 

(332,658

)

 

 

(578,140

)

Total interest expense

 

 

(767,443

)

 

 

(711,446

)

Exchange Gain or Loss

 

 

(4,664

)

 

 

 

Total other income (expense)

 

 

(772,107

)

 

 

(711,446

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(3,609,620

)

 

 

(3,920,922

)

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,609,620

)

 

$

(3,920,922

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share, basic and diluted

 

$

(0.36

)

 

$

(0.50

)

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, basic and diluted

 

 

10,037,905

 

 

 

7,844,127

 



See accompanying footnotes to these unaudited condensed consolidated financial statements.




2



 


SOCIAL REALITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)


 

 

Three Month Period Ended

March 31,

 

 

 

2018

 

 

2017

 

Cash flows from operating activities :

 

 

 

 

 

 

Net income (loss)

 

$

(3,609,620

)

 

$

(3,920,922

)

Adjustments to reconcile net loss to net cash used by operating activities:

 

 

 

 

 

 

 

 

Stock based compensation

 

 

166,130

 

 

 

512,442

 

Amortization of debt issue costs

 

 

93,639

 

 

 

578,140

 

Amortization of debt discount

 

 

239,018

 

 

 

 

Write-off of non-compete agreement

 

 

 

 

 

468,751

 

Provision for bad debts

 

 

(425

)

 

 

(8,277

)

Depreciation expense

 

 

9,441

 

 

 

3,234

 

Amortization of intangibles

 

 

166,185

 

 

 

107,720

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

2,614,671

 

 

 

1,840,549

 

Prepaid expenses

 

 

(72,416

)

 

 

2,071

 

Other assets

 

 

(3,445

)

 

 

 

Accounts payable and accrued expenses

 

 

(178,022

)

 

 

(195,150

)

Cash used by operating activities

 

 

(574,844

)

 

 

(611,442

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities :

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(20,793

)

 

 

(5,821

)

Development of software

 

 

(231,774

)

 

 

(135,241

)

Cash used in investing activities

 

 

(252,567

)

 

 

(141,062

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities :

 

 

 

 

 

 

 

 

Proceeds from the issuance of common stock, net

 

 

 

 

 

3,820,001

 

Repayments of note payable and PIK interest

 

 

 

 

 

(3,996,928

)

Net cash provided by financing activities

 

 

 

 

 

(176,927

)

 

 

 

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

 

(827,411

)

 

 

(929,431

)

Cash and cash equivalents, beginning of period

 

 

1,017,299

 

 

 

1,048,762

 

Cash and cash equivalents, end of period

 

$

189,888

 

 

$

119,331

 

 

 

 

 

 

 

 

 

 

Supplemental schedule of cash flow information :

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

340,684

 

 

$

550,695

 

Cash paid for taxes

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Supplemental Schedule of noncash financing activities :

 

 

 

 

 

 

 

 

Common stock issued for preferred stock conversion and vesting grants

 

$

 

 

$

52

 

Vesting of common stock award

 

$

150,000

 

 

$

 

Put liability on issuance of warrants

 

 

 

 

 

2,500,000

 

Issuance of common stock to be issued

 

$

869,500

 

 

$

100

 


 

See accompanying footnotes to these unaudited condensed consolidated financial statements.





3



 


SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 

NOTE 1 – DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION


Description of Business


Social Reality, Inc. ("Social Reality" or “SRAX”) is a Delaware corporation formed on August 2, 2011. These unaudited condensed consolidated financial statements include the consolidated results of Social Reality and its wholly owned subsidiary, Big Token, Inc. (“BigToken”) (collectively referred to as “we”, “us”, “our” or the “Company”). We are headquartered in Los Angeles, California.


We are a digital marketing and data management company that delivers our customers the ability to reach and engage with their target audiences


We derive our revenue from:


·

sales of digital advertising campaigns to advertising agencies and brands;

·

sales of media inventory owned by our publishing partners through real-time bidding, or RTB, exchanges;

·

sales and licensing of our SRAX Social platform and related media; and,

·

creation of custom platforms for buying media on SRAX for large brands.


Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements and notes thereto are unaudited. The unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and note disclosures normally included in the Company’s annual financial statements have been condensed or omitted. The December 31, 2017 condensed balance sheet data was derived from financial statements, but does not include all disclosures required by GAAP. These interim financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim three month period ended March 31, 2018 and 2017. The results for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any future period.

 

These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2017, included in the Company's annual report on Form 10-K filed with the SEC on April 2, 2018, as amended on Form 10-K/A (Amendment No. 1) as filed with the SEC on April 27, 2018.


NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Uses and Sources of Liquidity


Our primary need for liquidity is to fund working capital requirements of our business, development of internally used software and for general corporate purposes, including debt repayment. Our general, selling and administrative expenses decreased from $4,409,807 for the three months ended March 31, 2017 to $4,130,258 for the three months ended March 31, 2018. We incurred a loss of $3,609,620 for the three months ended March 31, 2018 compared to a net loss of $3,920,922 for the three months ended March 31, 2017. At March 31, 2018, we had an accumulated deficit of $24,758,326. As of March 31, 2018, we had $189,888 in cash and cash equivalents and a deficit in working capital of $1,917,197 as compared to $1,017,299 in cash and cash equivalents and a surplus in working capital of $1,124,023 at December 31, 2017. We continue to experience a period of limited liquidity resulting from the complete repayment of senior secured notes associated with a financing agreement previously held by Victory Park Management, LLC and the repurchase of the Series B Warrants, both in April 2017. Additionally, in October 2017 we satisfied all amounts outstanding to Victory Park Management, LLC related to its put right for the repurchase of the Financing Warrant (as defined in Note 8), amounting to $1,500,000 plus accrued interest. See Note 8 for a further discussion of this obligation.




4



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


We acknowledge that we continue to face a challenging competitive environment and while we continue to focus on our overall profitability, including managing expenses, we reported losses and have historically required funding of cash used in operating and investing activities with cash provided by financing activities. We expect that the actions initiated in the second half of 2017 will enhance our liquidity and financial flexibility in the first half of 2018. In late 2017, we announced several new revenue initiatives that could provide additional revenue growth opportunities anticipated to begin in the second half of 2018. In late 2017, we also announced that we had engaged outside advisors to evaluate potential strategic opportunities for our SRAXmd product group that could ultimately result in a sale of that product line, potentially adding additional liquidity for the Company.


We believe that the actions discussed above are probable of occurring and will enable us to satisfy our estimated liquidity needs 12 months from the issuance of the financial statements. However, we cannot predict, with certainty, the outcome of our actions to generate liquidity or whether such actions would generate the expected liquidity as currently planned. If we continue to experience operating losses, and we are not able to generate additional liquidity through the mechanisms described above or through some combination of other actions, while not expected, we may not be able to access additional funds and we might need to secure additional sources of funds, which may or may not be available to us under terms and conditions that are favorable to our success. Additionally, a failure to generate additional liquidity could negatively impact our access to services that are important to the operation of our business.


Effect of Reverse Stock Split on Presentation


In September 2016, the Company completed a 1 for 5 reverse stock split of our Class A common stock. These unaudited condensed consolidated financial statements give retroactive effect to the reverse stock split for all periods presented, unless otherwise specified.


Effect of ASU No. 2017-11 on Previously Issued Financial Statements


In July 2017, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 – Accounting for Certain Financial Instruments with Down Round Features and Part 2 – Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception (“ASU No. 2017-11”). Part 1 of ASU No. 2017-11 addresses the complexity of accounting for certain financial instruments with down round features. Down round features are provisions in certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of ASU No. 2017-11 addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification ®. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018.


The Company early adopted the guidance under ASU 2017-11 for the year end December 31, 2017, and recognized warrants issued in 2017 with a down round feature as equity.  Adjustments to the Company’s previously issued financial statements were required for the retrospective application of this standard. As such the financial statements for three month period ended March 31, 2017 have been reclassified to reflect the adoption of ASU 2017-11.  





5



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 



 

 

March 31,

2017

 

 

 

 

 

March 31,

2017

 

 

 

As Reported

 

 

Adjustments

 

 

As Adjusted

 

Assets

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

119,331

 

 

 

 

 

 

119,331

 

Accounts receivable, net

 

 

6,578,747

 

 

 

 

 

 

6,578,747

 

Prepaid expenses

 

 

330,432

 

 

 

 

 

 

330,432

 

Other current assets

 

 

6,488

 

 

 

 

 

 

6,488

 

Total current assets

 

 

7,034,998

 

 

 

 

 

 

7,034,998

 

Property and equipment, net

 

 

58,079

 

 

 

 

 

 

58,079

 

Goodwill

 

 

15,644,957

 

 

 

 

 

 

15,644,957

 

Intangibles assets, net

 

 

924,011

 

 

 

 

 

 

924,011

 

Other assets

 

 

34,659

 

 

 

 

 

 

34,659

 

Total assets

 

 

23,696,704

 

 

 

 

 

 

23,696,704

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

12,960,933

 

 

 

 

 

 

12,960,933

 

Note payable, net of unamortized costs

 

 

 

 

 

 

 

 

 

Put warrant liability

 

 

1,143,781

 

 

 

(1,143,781

)

 

 

 

Put liability

 

 

1,500,000

 

 

 

 

 

 

1,500,000

 

Total current liabilities

 

 

15,604,714

 

 

 

(1,143,781

)

 

 

14,460,933

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 11)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively

 

 

 

 

 

 

 

 

 

Class A common stock, authorized 50,000,000 shares, $0.001 par value, 8,025,017 and 6,951,077 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively

 

 

8,025

 

 

 

 

 

 

8,025

 

Class B common stock, authorized 9,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively

 

 

 

 

 

 

 

 

 

Common stock to be issued

 

 

 

 

 

 

 

 

 

Additional paid in capital

 

 

24,500,328

 

 

 

-

 

 

 

24,500,328

 

Accumulated deficit

 

 

(16,416,363

)

 

 

1,143,781

 

 

 

(15,272,582

)

Total stockholders' equity

 

 

8,091,990

 

 

 

1,143,781

 

 

 

9,235,771

 

Total liabilities and stockholders' equity

 

 

23,696,704

 

 

 

-

 

 

 

23,696,704

 





6



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 



 

 

Three Month Period ended

 

 

 

 

 

Three Month Period ended

 

 

 

March 31,

2017

 

 

 

 

 

March 31,

2017

 

 

 

As Reported

 

 

Adjustments

 

 

As Adjusted

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

5,326,163

 

 

 

 

 

 

5,326,163

 

Cost of revenue

 

 

3,279,120

 

 

 

 

 

 

3,279,120

 

Gross profit

 

 

2,047,043

 

 

 

 

 

 

 

2,047,043

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expense

 

 

 

 

 

 

 

 

 

 

 

 

General, selling and administrative expense

 

 

4,409,807

 

 

 

 

 

 

4,409,807

 

Write-off of non-compete agreement

 

 

468,751

 

 

 

 

 

 

468,751

 

Restructuring costs

 

 

377,961

 

 

 

 

 

 

377,961

 

Total operating expense, net

 

 

5,256,519

 

 

 

 

 

 

5,256,519

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(3,209,476

)

 

 

 

 

 

(3,209,476

)

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

Interest expense:

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(133,306

)

 

 

 

 

 

(133,306

)

Amortization of debt issuance costs

 

 

(578,140

)

 

 

 

 

 

(578,140

)

Total interest expense

 

 

(711,446

)

 

 

 

 

 

(711,446

)

Accretion of put warrants

 

 

1,894,563

 

 

 

(1,894,563

)

 

 

 

Total other income (expense)

 

 

1,183,117

 

 

 

(1,894,563

)

 

 

(711,446

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(2,026,359

)

 

 

(1,894,563

)

 

 

(3,920,922

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

(2,026,359

)

 

 

(1,894,563

)

 

 

(3,920,922

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share, basic and diluted

 

 

(0.26

)

 

 

(0.24

)

 

 

(0.50

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding, basic and diluted

 

 

7,844,127

 

 

 

 

 

 

7,844,127

 






7



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 



 

 

Three Month Period Ended

 

 

 

 

 

Three Month Period ended

 

 

 

March 31,

2017

 

 

 

 

 

March 31,

2017

 

 

 

As Reported

 

 

Adjustments

 

 

As Adjusted

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

Net loss

 

 

(2,026,359

)

 

 

(1,894,563

)

 

 

(3,920,922

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock based compensation

 

 

512,442

 

 

 

 

 

 

512,442

 

Amortization of debt issuance costs

 

 

578,140

 

 

 

 

 

 

578,140

 

Accretion of put warrants

 

 

(1,894,563

)

 

 

1,894,563

 

 

 

 

Write-off of non-compete agreement

 

 

468,751

 

 

 

 

 

 

468,751

 

Provision for bad debts

 

 

(8,277

)

 

 

 

 

 

(8,277

)

Depreciation expense

 

 

3,234

 

 

 

 

 

 

3,234

 

Amortization of intangibles

 

 

107,720

 

 

 

 

 

 

107,720

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

1,840,549

 

 

 

 

 

 

1,840,549

 

Prepaid expenses

 

 

2,071

 

 

 

 

 

 

2,071

 

Other current assets

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

(195,150

)

 

 

 

 

 

(195,150

)

Unearned revenue

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(611,442

)

 

 

 

 

 

(611,442

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(5,821

)

 

 

 

 

 

(5,821

)

Development of software

 

 

(135,241

)

 

 

 

 

 

(135,241

)

Net cash used in investing activities

 

 

(141,062

)

 

 

 

 

 

(141,062

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from the issuance of common stock

 

 

3,820,001

 

 

 

 

 

 

3,820,001

 

Proceeds from notes payable

 

 

 

 

 

 

 

 

 

 

Repayments of note payable and PIK interest

 

 

(3,996,928

)

 

 

 

 

 

(3,996,928

)

Net cash (used in) provided by financing activities

 

 

(176,927

)

 

 

 

 

 

(176,927

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

 

(929,431

)

 

 

 

 

 

 

(929,431

)

Cash and cash equivalents, beginning of period

 

 

1,048,762

 

 

 

 

 

 

1,048,762

 

Cash and cash equivalents, end of period

 

 

119,331

 

 

 

 

 

 

119,331

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental schedule of cash flow information

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

 

 

550,695

 

 

 

 

 

 

550,695

 

Cash paid for taxes

 

 

 

 

 

 

 

 

 



 




8



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Principles of Consolidation


The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation.


Use of Estimates


The unaudited condensed consolidated financial statements have been prepared in conformity with GAAP and requires management of the Company to make estimates and assumptions in the preparation of these unaudited condensed consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting periods. Actual results could differ from these estimates and assumptions.


The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company's revenue recognition, allowance for doubtful accounts and sales credits, stock-based compensation, income taxes, goodwill, other intangible assets, put rights and valuation of liabilities.


Cash and Cash Equivalents


The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents.


Revenue Recognition


The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists; no significant Company obligations remain; collection of the related receivable is reasonably assured; and the fees are fixed or determinable. The Company acts as a principal in revenue transactions as the Company is the primary obligor in the transactions. As such, revenue is recognized on a gross basis, and media and publisher expenses that are directly related to a revenue-generating event are recorded as a component of cost of revenue.


Cost of Revenue


Cost of revenue consists of payments to media providers and website publishers that are directly related to either a revenue-generating event or project and application design costs. The Company becomes obligated to make payments related to media providers and website publishers in the period the advertising impressions, click-through, actions or lead-based information are delivered or occur. Such expenses are classified as cost of revenue in the corresponding period in which the revenue is recognized in the accompanying unaudited condensed consolidated statements of operations.


Accounts Receivable


Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company's accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company does not require collateral. Allowance for doubtful accounts was $59,278 and $59,703 at March 31, 2018 and December 31, 2017, respectively.


Concentration of Credit Risk, Significant Customers and Supplier Risk


Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The Company has not experienced any loss on these accounts. The balances are maintained in demand accounts to minimize risk.




9



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


At March 31, 2018, three customers accounted for more than 10% of the accounts receivable balance for a total of 57.4%. At December 31, 2017, four customers accounted for more than 10% of the accounts receivable balance for a total of 59.5%.


For the three months ended March 31, 2018, two customers accounted for more than 10% of total revenue for a total of 44.9%. For the three months ended March 31, 2017, one customer accounted for 25.9% of total revenue.


Fair Value of Financial Instruments


The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

 

Level 1 Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; 

 

 

Level 2 Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

 

Level 3 Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.


The Company's financial instruments, including cash and cash equivalents, net accounts receivable, accounts payable and accrued expenses, are carried at historical cost. At March 31, 2018 and December 31, 2017, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Black Scholes Merton model.


Property and equipment


Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years.


Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment.


Intangible assets


Intangible assets consist of intellectual property, a non-complete agreement, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of three to six years.  During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred.  The Company capitalizes the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use.



10



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Business Combinations


For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition.


Goodwill and annual impairment testing period


Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company assesses goodwill for impairment at least annually, or when events or changes in the business environment indicate the carrying value may not be fully recoverable. The Company also has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads the Company to determine that it is more likely than not (that is, a likelihood of more than 50%) that goodwill is impaired. If the Company chooses to first assess qualitative factors and it is determined that it is not more likely than not goodwill is impaired, the Company is not required to take further action to test for impairment. The Company also has the option to bypass the qualitative assessment and perform only the quantitative impairment test, which the Company may choose to do in some periods but not in others. The Company performs its annual impairment review as of December 31 st .


The Company had historically performed its annual goodwill and impairment assessment on September 30 th of each year. Due to the seasonal and cyclical nature of advertising sales in general, timing of the Company’s annual budgeting process, and the short-term nature of the Company’s advertising sales contracts, it was determined that it would be more effective and efficient to conduct the annual impairment analysis instead at December 31 st of each year. This would also better align the Company with other advertising sales companies who also generally conduct this annual analysis in the fourth quarter. The Company changed the date for its impairment testing during the fourth quarter 2016. The Company does not believe this change had any material impact on its unaudited condensed consolidated financial statements, and continues to evaluate potential interim impairment to goodwill consistent with its historical practices.


When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company's products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company's reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to a two-step impairment testing methodology using the income approach (discounted cash flow method).


In the first step of the two-step testing methodology, we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, we then complete the second step of the impairment test to determine the amount of impairment to be recognized. In the second step, we estimate an implied fair value of the reporting unit's goodwill by allocating the fair value of the reporting unit to 100% of the assets and liabilities other than goodwill (including any unrecognized intangible assets). If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference in that period.


When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.




11



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The impairment charge represents the excess of the carrying amount of the goodwill recorded in the acquisition over the implied fair value of the goodwill. The implied fair value of the goodwill is the residual fair value based on an income approach that utilized a discounted cash flow model based on revenue and profit forecasts. The Company performed its annual impairment test and no impairment of goodwill has been recorded during the three months ended March 31, 2018 or 2017, respectively.


Long-lived Assets


Management evaluates the recoverability of the Company's identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company's stock price for a sustained period of time; and changes in the Company's business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets' carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.


No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the three months ended March 31, 2018 or 2017, respectively.


Derivatives


The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, Distinguishing Liabilities From Equity and FASB ASC Topic No. 815, Derivatives and Hedging .  Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments.


Loss Per Share


We use Accounting Standards Codification (“ASC”) 260, " Earnings Per Share " for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share are the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.


There were 5,053,258 common share equivalents at March 31, 2018 and 3,619,331 common share equivalents at March 31, 2017. For the three months ended March 31, 2018 and 2017, respectively, these potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.


Income Taxes


We utilize ASC 740 “ Income Taxes ” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 



12



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The Company recognizes the impact of a tax position in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.


Stock-Based Compensation


We account for our stock based compensation under ASC 718 " Compensation – Stock Compensation " using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity's equity instruments or that may be settled by the issuance of those equity instruments.


We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.


Common stock awards

 

The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.

 

Warrants

 

In connection with certain financing, consulting and collaboration arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11, Stockholders’ Equity .


Business Segments


The Company uses the "management approach" to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company's reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics.


NOTE 3 – IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS


Adoption of New Accounting Standards


For a discussion of recent accounting pronouncements, please refer to Recently Issued Accounting Standards as contained in Note 1 in the December 31, 2017 audited consolidated financial statements included in the Company’s annual report on Form 10-K filed with the SEC on April 2, 2018.


During the three months ended March 31, 2018, the Company adopted no new Accounting Standards.




13



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Accounting Standards Issued But Not Yet Effective


In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842). The effective date for ASU 2017-13 is for fiscal years beginning after December 15, 2018. The adoption of this ASU will not have a material impact to our consolidated financial statements.


In July 2017, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 – Accounting for Certain Financial Instruments with Down Round Features and Part 2 – Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception (“ASU No. 2017-11”). Part 1 of ASU No. 2017-11 addresses the complexity of accounting for certain financial instruments with down round features. Down round features are provisions in certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of ASU No. 2017-11 addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification ®. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. We early adopted the proposed guidance under ASU 2017-11 for the year end December 31, 2017, and recognized warrants issued in the fourth quarter of 2017 with a down round feature as equity. Adjustments to the Company’s previously issued financial statements were required for the retrospective application of this standard.


In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU No. 2017-04”). ASU No. 2017-04 simplifies the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. A public business entity that is a SEC filer should adopt the amendments of ASU No. 2017-04 for its annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company does not expect any impact from the adoption of this standard on its consolidated financial statements.


In October 2016, the FASB issued ASU No. 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory (“ASU No. 2016-16”). ASU No. 2016-16 will require the tax effects of intercompany transactions, other than sales of inventory, to be recognized currently, eliminating an exception under current GAAP in which the tax effects of intra-entity asset transfers are deferred until the transferred asset is sold to a third party or otherwise recovered through use. The guidance will be effective for the first interim period of our 2019 fiscal year, with earlier adoption permitted.


In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU No. 2016-15”). ASU No. 2016-15 provides guidance regarding the classification of certain items within the statements of cash flows. ASU No. 2016-15 is effective for annual periods beginning after December 15, 2017 with early adoption permitted.


In connection with its financial instruments project, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments in June 2016 and ASU No. 2016-01, Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities in January 2016.


·

ASU No. 2016-13 introduces a new impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, entities will be required to use a forward-looking “expected loss” model that will replace the current “incurred loss” model and generally will result in earlier recognition of allowances for losses. The guidance will be effective for the first interim period of our 2021 fiscal year, with early adoption in fiscal year 2020 permitted.




14



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 





·

ASU No. 2016-01 addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. Among other provisions, the new guidance requires the fair value measurement of investments in certain equity securities. For investments without readily determinable fair values, entities have the option to either measure these investments at fair value or at cost adjusted for changes in observable prices minus impairment. All changes in measurement will be recognized in net income. The guidance will be effective for the first interim period of our 2019 fiscal year. Early adoption is not permitted, except for certain provisions relating to financial liabilities.


In April 2016, the FASB issued ASU No. 2016-10, Identifying Performance Obligations and Licensing (Topic 606) , which amends certain aspects of the FASB’s new revenue standard, ASU No. 2014-09, Revenue from Contracts with Customer (Topic 606) . ASU No. 2016-10 identifies performance obligations and provides licensing implementation guidance. The effective date for ASU No. 2016-10 is the same as the effective date of ASU No. 2014-09. ASU No. 2015-14 , Revenue from Contracts with Customers (Topic 606): Deferral of Effective Date defers the effective date of ASU No. 2014-09 by one year, for fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.


In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customer (Topic 606): Principal versus Agent Considerations - Reporting Revenue Gross versus Net , (ASU No. 2016-08) that clarifies how to apply revenue recognition guidance related to whether an entity is a principal or an agent. ASU No. 2016-08 clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer and provides additional guidance about how to apply the control principle when services are provided and when goods or services are combined with other goods or services. The effective date for ASU No. 2016-08 is the same as the effective date of ASU No. 2014-09. ASU No. 2015-14 defers the effective date of ASU No. 2014-09 by one year, for fiscal years beginning after December 15, 2017. The Company has performed an evaluation of the impact of the adoption of this standard on its consolidated financial statements, and given its revenue recognition practices already in place, it does not appear this will have a material impact on the Company’s future presentation of consolidated financial statements. The Company will continue to evaluate new revenue streams as they develop from future new product launches.


In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this standard on its consolidated financial statements.


Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements.


NOTE 4 – ACQUISITIONS


On October 30, 2014, we acquired 100% of the capital stock of Steel Media from Richard Steel pursuant to the terms and conditions of a stock purchase agreement, dated October 30, 2014, by and among the Company, Steel Media and Mr. Steel (the "Stock Purchase Agreement").


The Company did not engage in any acquisition activity during the three months ended March 31, 2018 or during the twelve months ended December 31, 2017.


On October 17, 2017, the Company issued a press release announcing it has engaged financial advisors to explore strategic alternatives for the company's SRAXmd business.




15



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


NOTE 5 – PROPERTY AND EQUIPMENT, NET


Property and equipment consists of the following at March 31, 2018 and December 31, 2017:


 

 

March 31,

2018

 

 

December 31,

2017

 

Office equipment

 

$

272,207

 

 

$

251,415

 

Accumulated depreciation

 

 

(106,309

)

 

 

(96,869

)

Property and equipment, net

 

$

165,898

 

 

$

154,546

 


Depreciation expense for the three months ended March 31, 2018 and 2017 was $9,441 and $3,234, respectively.


NOTE 6 – INTANGIBLE ASSETS, NET


Intangible assets consist of the following:


 

 

March 31,

2018

 

 

December 31,

2017

 

Non-compete agreement

 

$

1,250,000

 

 

$

1,250,000

 

Intellectual property

 

 

756,000

 

 

 

756,000

 

Acquired software - Leapfrog

 

 

617,069

 

 

 

617,069

 

Internally developed software

 

 

985,914

 

 

 

754,140

 

 

 

 

3,608,983

 

 

 

3,377,209

 

Accumulated amortization

 

 

(1,900,634

)

 

 

(1,734,449

)

Carrying value

 

$

1,708,349

 

 

$

1,642,760

 


During the three months ended March 31, 2018, the Company capitalized $231,774 of costs associated with the development of internal-use software, including directly related payroll costs.


On August 17, 2017, the Company acquired software from Leapfrog Media Trading in exchange for 200,000 shares of Class A common stock and 350,000 warrants with a term of five years and an exercise price of $3.00. This software is currently being integrated into our platform and we estimate launching on July 1, 2018. No other assets, customers, employees, intangibles or business operations were acquired in this transaction.


In connection with a separation and release agreement with Mr. Steel, the Company agreed to reduce the remaining period of the non-compete agreement with Mr. Steel, which was entered into as a result of the acquisition of Steel Media, to a period of eighteen months from the date of his separation from the Company. Accordingly, the Company wrote off $468,750 in value of the non-compete agreement during 2017.


Amortization expense was $37,800 for intellectual property, $52,083 for the non-compete agreement and $76,301 for the internally developed software for the three months ended March 31, 2018. Amortization expense was $37,800 for intellectual property, $52,083 for the non-compete agreement, and $17,837 for the internally developed software for the three months ended March 31, 2017.




16



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The estimated future amortization expense for the remainder of 2018 and the years ended December 31 thereafter, are as follows:


Remainder of 2018

 

$

514,592

 

2019

 

 

662,094

 

2020

 

 

205,690

 

2021

 

 

325,973

 

 

 

$

1,708,349

 


NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES


Accounts payable and accrued expenses are comprised of the following:


 

 

March 31,

2018

 

 

December 31,

2017

 

Accounts payable, trade

 

$

3,145,279

 

 

$

2,858,871

 

Accrued expenses

 

 

1,440,440

 

 

 

1,800,621

 

Accrued compensation

 

 

94,128

 

 

 

256,164

 

Accrued commissions

 

 

2,947

 

 

 

95,159

 

Total

 

$

4,682,794

 

 

$

5,010,815

 


NOTE 8 – NOTES PAYABLE


Financing Agreement with Victory Park Management, LLC as agent for the lenders


On October 30, 2014 (the "Financing Agreement Closing Date"), the Company entered a financing agreement (the "Financing Agreement") with Victory Park Management, LLC, as administrative agent and collateral agent for the lenders and holders of notes and warrants issued thereunder (the "Agent"). The initial and subsequent notes issued (the “Financing Notes”) bore interest at a rate per annum equal to the sum of (1) cash interest at a rate of 10% per annum and (2) payment-in-kind (PIK) interest at a rate of 4% per annum for the period commencing on the Financing Agreement Closing Date and extending through the last day of the calendar month during which the Company's financial statements for December 31, 2014 are delivered, and which PIK interest rate thereafter from time to time may be adjusted based on the ratio of the Company's consolidated indebtedness to its earnings before interest, taxes, depreciation and amortization. If the Company achieved a reduction in the leverage ratio as described in the Financing Agreement, the PIK interest rate declined on a sliding scale from 4% to 2%. The Financing Notes issued under the Financing Agreement were scheduled to mature on October 30, 2017.


During 2017, we completely repaid the Financing Notes and made principal and PIK interest repayments in the amount of $3,996,928.


Notes payable consisted of the following at December 31, 2017:


We incurred a total of $3,164,352 of costs related to the Financing Agreement. These costs were amortized to interest expense over the life of the debt. During the three months ended March 31, 2018 and 2017, $0 and $578,140, respectively, of debt issuance costs were amortized as interest expense. As of March 31, 2018, all deferred debt issuance costs have been completely amortized.


During the three months ended March 31, 2018 and 2017, $0 and $0, respectively, were recorded as PIK interest expense.




17



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Pursuant to the Financing Agreement, the Company issued to the lender a five-year warrant to purchase 580,000 shares of its Class A common stock at an exercise price of $5.00 per share (the "Financing Warrant"). The warrant holder was not, however, permitted to exercise the Financing Warrant for shares of Class A common stock that would cause such holder to beneficially own shares of Class A common stock that exceeds 4.99% of the Company's outstanding shares of Class A common stock following such exercise. Pursuant to the Financing Warrant, the warrant holder had the right, at any time after the earlier of April 30, 2016 and the maturity date of the Financing Notes issued, but prior to October 30, 2019, to exercise its put right under the terms of the Financing Warrant, pursuant to which the warrant holder may sell to the Company, and the Company will purchase from the warrant holder, all or any portion of the Financing Warrant that had not been previously exercised. In connection with any exercise of this put right, the purchase price was to equal to an amount based upon the percentage of the Financing Warrant for which the put right is being exercised, multiplied by the lesser of (a) 50% of the total consolidated revenue for the Company for the trailing 12-month period ending with the Company's then-most recently completed fiscal quarter, and (b) $1,500,000. In May 2017, the Company was notified by the warrant holder that it was exercising its put right. We had a period of 45 days from the date of notice to repay the right or negotiate a settlement. If the right remained unpaid after the 45-day period, interest would accrue on the unpaid balance at a rate of 14% per annum. On October 27, 2017, the Company paid the warrant holder $1,567,612, which was comprised of the $1,500,000 warrant value and an additional $67,612 of accrued interest.


As contemplated under the Financing Agreement, the Company also entered a registration rights agreement on the Financing Agreement Closing Date (the "Financing Registration Rights Agreement") with the holder of the Financing Warrant, pursuant to which the Company granted to such holder certain "piggyback" rights to register the shares of the Company's Class A common stock issuable upon exercise of the Financing Warrant. Specifically, the holder of the Financing Warrant had the right, subject to certain allocation provisions set forth in the Financing Registration Rights Agreement, to include the shares underlying the Financing Warrant in registration statements for offerings by the Company of its Class A common stock, as well as offerings of the Company's Class A common stock held by third parties. The shares underlying the Financing Warrant were initially included in a Post-Effective Amendment No. 1 to the registration statement on Form S-1 that was declared effective by the SEC in March 2016.


Financing and Security Agreement with FastPay


In September 2016, the Company executed a Financing and Security Agreement, as amended (collectively, the "FastPay Agreement"). with FastPay Partners, LLC to create an accounts receivable-based credit facility. The FastPay Agreement was further amended in April 2018.


Under the April 2018 amended terms of the FastPay Agreement, FastPay may, at its sole discretion, purchase the Company's eligible accounts receivable. Upon any acquisition of accounts receivable, FastPay will advance the Company up to 80% of the gross value of the purchased accounts, up to a maximum of $4,000,000 in advances. Each account receivable purchased by FastPay will be subject to a factoring fee rate specified in the FastPay Agreement calculated as a percentage of the gross value of the account outstanding and additional fees for accounts outstanding over 30 days. The Company is subject to a concentration limitation on the percentage of debt from any single customer of 25% to the total amount outstanding on its purchased accounts, subject to an increase to 30% for one specific large customer.


The Company is obligated to repurchase accounts remaining uncollected after a specified deadline, and FastPay will generally have full recourse against the Company in the event of nonpayment of any purchased accounts. The Company's obligations under the FastPay Agreement are secured by a first position security interest in its accounts receivable, deposit accounts and all proceeds therefrom.


The FastPay Agreement contains covenants that are customary for agreements of this type and are primarily related to accounts receivable and audit rights. The Company is also required to provide FastPay with 30-day notice of any transaction that result, or would result in, a “change of control” as defined in the FastPay Agreement. The failure to satisfy covenants under the FastPay Agreement or the occurrence of other specified events that constitute an event of default, as defined, could result in the termination of the FastPay Agreement and/or the acceleration of the Company's obligations. The FastPay Agreement contains provisions relating to events of default that are customary for agreements of this type.




18



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The current FastPay Agreement has a term of 18 months and automatically renews thereafter for successive one-year terms, subject to earlier termination by written notice by the Company, provided all obligations are paid, including the payment of an early termination fee.


At March 31, 2018, $1,287,176 of accounts receivable purchased by FastPay remain outstanding and are subject to repurchase under the terms of the FastPay Agreement.


NOTE 9 – PUT WARRANT LIABILITY


As more fully described in Note 11, the Company issued Series A Warrants and Series B Warrants in connection with a securities purchase agreement dated January 4, 2017.  At issuance, the Series A Warrants and the Series B Warrants were accounted for utilizing ASC 815  “Derivatives and Hedging”.  The Company incurred a liability for the estimated fair value of derivative warrant instruments. The estimated fair value of the derivative warrant instruments was calculated using the Black-Scholes fair value option-pricing model with key input variables provided by management, as of the date of issuance, with the valuation offset against additional paid in capital, and at each reporting date, with changes in fair value recorded as gains or losses on revaluation in other income (expense).


The Company identified embedded derivatives related to the warrants issued. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the warrants and to adjust the fair value as of each subsequent balance sheet date. At the inception of the warrants, the Company determined a fair value of $3,038,344 of the embedded derivatives.

On January 4, 2017, the date of inception, the fair value of the embedded derivatives was determined using the Black-Scholes Model based on a risk-free interest rate of 2% for both the Series A Warrants and the Series B Warrants, an expected term of 5.5 years for the Series A Warrants and 5 years for the Series B Warrants, an expected volatility of 110% for the Series A Warrants and the Series B Warrants and a 0% dividend yield for the Series A Warrants and the Series B Warrants, respectively.


Fair value at March 31, 2017 was estimated to be $1,143,781 and based on a risk-free interest rate of 1.875% for both the Series A Warrants and the Series B Warrants, an expected term of 5.25 years for the Series A Warrants and 4.75 years for the Series B Warrants, an expected volatility of 110% for the Series A Warrants and the Series B Warrants and a 0% dividend yield for the Series A Warrants and the Series B Warrants, respectively.


During the period ended March 31, 2017, the decrease in the fair value of the warrant derivative liability of $1,894,563 was recorded as a gain on change in fair value of derivative liability.


In July 2017, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 – Accounting for Certain Financial Instruments with Down Round Features and Part 2 – Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception (“ASU No. 2017-11”). Part 1 of ASU No. 2017-11 addresses the complexity of accounting for certain financial instruments with down round features. Down round features are provisions in certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of ASU No. 2017-11 addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification ®. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. For public business entities, the amendments in Part I of this update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018.




19



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The Company chose to early adopt the guidance under ASU 2017-11 for the year end December 31, 2017, and recognized all  warrants issued in 2017 with a down round features as equity.  Adjustments to the Company’s previously issued financial statements were required for the retrospective application of this standard.  As such the financial statements for three month period ended March 31, 2017 have been reclassified to reflect the adoption of ASU 2017-11.


The put warrant liability is comprised of the following at March 31, 2017:


 

 

March 31,

2017

 

 

Adjustments

 

 

March 31,

2017

 

Initial derivative liability on issuance of put warrants

 

$

3,038,344

 

 

$

(3,038,344

)

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Less accretion of put warrants

 

 

(1,894,563

)

 

 

1,894,563

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Put warrant liability

 

$

1,143,781

 

 

$

(1,143,781

)

 

$

 


In April 2017, the Company repurchased the Series B Warrants for $2,500,000.


As a result of the sale of the Debentures (see Note 10), the exercise price of the Series A Warrants issued to investors in our January 2017 private offering was reset to $2.245 per share. The Company recognized a loss on the repricing of these warrants amounting to $99,820.


NOTE 10 – SECURED CONVERTIBLE DEBENTURES, NET


In April 2017, the Company entered into definitive securities purchase agreements (the “Securities Purchase Agreements”) with certain accredited investors (the “Purchasers”) for the purchase and sale of an aggregate of : (i) $5,000,000 principal amount of 12.5% secured convertible debentures (the “Debentures”); and (ii) five-year Series A warrants (the “Debenture Warrants”) representing the right to acquire up to 833,337 shares of our Class A common stock in a transaction exempt from registration under the Securities Act, in reliance on an exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act.


The Debentures, which mature three years from the date of issuance, pay interest in cash at the rate of 12.5% per annum, payable quarterly on January 1, April 1, July 1 and October 1, beginning on July 1, 2017. Our obligations under the Debentures are secured by a second position security interest in our accounts receivable and a first position security interest in the balance of our assets, and we are subject to continued compliance with certain financial covenants. The Debentures are convertible at the option of the holder into shares of our Class A common stock at an initial conversion price of $3.00 per share, subject to adjustment as hereinafter set forth. Subject to our compliance with certain equity conditions set forth in the Debentures, upon 20 trading days' notice to the holders we have the right to redeem the Debentures in cash at a 120% premium during the first year and a 110% premium during the remaining term of the Debentures. Upon any optional redemption, we are obligated to issue the holder five-year warrant Series B warrants, the terms of which will be identical to the Debenture Warrants, to purchase a number of shares of our Class A common stock as shall equal 50% of conversion shares issuable on an as-converted basis as if the principal amount of the Debenture had been converted immediately prior to the optional redemption. In the event of future financings by us, subject to certain exempt issuances, the holders have the right to cause us to allocate 20% of the proceeds we may receive as a mandatory redemption of a portion of the principal amount then outstanding. We are also required to redeem the Debentures upon our failure to maintain certain financial covenants which include a minimum monthly current ratio, a maximum quarterly corporate expense ratio, and maintain minimum quarterly revenue and EBITDA related to SRAXmd . As of March 31, 2018, we are in compliance with all financial covenants.




20



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The Debenture also contains certain customary events of default (including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, changes in control of the Company and the entering or filing of certain monetary judgments against the Company). Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture, plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the holder’s election, immediately due and payable in cash. The Company is also subject to certain customary non-financial covenants under the Debenture. The Debenture holders were granted board observation rights so long as the lead investor continues to hold the Debentures.


The Debenture Warrants are initially exercisable at $3.00 per share and, if at any time after the six-month anniversary of the issuance the underlying shares of our Class A common stock are not covered by an effective resale registration statement, the Debenture Warrants are exercisable on a cashless basis. The conversion price of the Debentures and the exercise price of the Debenture Warrants are subject to adjustments upon certain events, including stock splits, stock dividends, subsequent equity transactions (other than specified exempt issuances), subsequent rights offerings, and fundamental transactions, subject to a floor of $1.40 per share. If we fail to timely deliver the shares of our Class A common stock upon any conversion of the Debentures or exercise of the Debenture Warrants we will be subject to certain buy-in provisions. Pursuant to the terms of the Debentures and Debenture Warrants, a holder will not have the right to convert any portion of the Debentures or exercise any portion of the Debenture Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares of Class A common stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Debenture Warrants; provided that after the Shareholder Approval Date, as defined below, at the election of a holder and notice to us such percentage ownership limitation may be increased or decreased to any other percentage, not to exceed 9.99%; provided that any increase will not be effective until the 61 st day after such notice is delivered from the holder to us.


In accordance with the Nasdaq Marketplace Rules, until such time as our stockholders have approved the Securities Purchase Agreements and the transactions thereunder (the "Shareholder Approval Date"), we were not obligated to issue any shares of our Class A common stock upon any conversion of the Debentures and/or exercise of the Debenture Warrants, and the holders had no right to receive upon conversion and/or exercise thereof any shares of our Class A common stock, to the extent the issuance of such shares of Class A common stock would exceed 20% of our outstanding Class A common stock prior to the transaction. We held a special meeting of the shareholders on June 23, 2017 whereby we obtained approval of the Securities Purchase Agreements and the transactions thereunder.


We agreed to file a registration statement registering the resale of the shares of our Class A common stock underlying the Debentures and the Debenture Warrants. Under the terms of the Securities Purchaser Agreements, we also granted the Purchasers of the Debentures the right to purchase an additional $3,000,000 of Debentures upon the same terms and conditions for a period beginning on the Shareholder Approval Date and expiring on earliest of the date that (a) the initial registration statement has been declared effective by the SEC, (b) all of the underlying shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for our company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the closing date provided that a holder of the underlying shares is not an affiliate of the Company or (d) all of the underlying shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act. The shares underlying the Debentures and Debenture Warrants were included in a resale registration statement on Form S-3 that was declared effective by the SEC in June 2017.




21



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Chardan Capital Markets, LLC (“Chardan Capital”), Noble Capital Markets, Inc. ("Noble") and Aspenwood Capital (an independent branch of Colorado Financial Services Corporation) (“Aspenwood”), all broker-dealers and members of FINRA, acted as either our placement agent or a finder in connection with the sale of the securities pursuant to the Securities Purchase Agreements. In addition, an affiliate of Noble purchased Debentures amounting to $720,000 and was issued Debenture Warrants to purchase 120,000 shares of our Class A common stock in this offering. We paid aggregate cash commissions amounting to $276,700 to these broker-dealers in connection with the sale of the Debentures. Additionally, we issued Chardan Capital placement agent warrants ("Chardan Placement Agent Warrants") to purchase 100,000 shares of our Class A common stock at an exercise price of $3.75 per share which are exercisable for 5.5 years commencing six months from the issuance date. We issued Noble placement agent warrants (“Noble Placement Agent Warrants”) to purchase up to 66,800 shares of our Class A common stock at an exercise price of $3.00 per share which will become exercisable six months from the date of issuance. We also issued Colorado Financial Service Corporation and its designees warrants (“Aspenwood Warrants”) to purchase 7,700 shares of our Class A common stock at an exercise price of $3.75 per share which are exercisable for 5.5 years commencing six months from the issuance date. We included the shares underlying the Chardan Placement Agent Warrants, the Noble Placement Agent Warrants, and the Aspenwood Warrants in the afore-described resale registration statement that was declared effective by the SEC in June 2017.


The net proceeds to us from the offering, after deducting placement agent fees and estimated offering expenses, were approximately $4,566,405. We utilized $2,500,000 of the net proceeds to satisfy a put obligation under the Series B Warrants issued to investors in a registered direct offering that we conducted in January 2017 as described in Note 11. The balance of the net proceeds was used to pay down accounts payable and satisfy other working capital requirements.


On October 26, 2017, the Company entered into definitive securities purchase agreements (the “Securities Purchase Agreement”) with certain prior accredited investors (the “Purchasers”) for the purchase and sale of an aggregate of: (i) $5,180,157.78 in principal amount of 12.5% secured convertible debentures (the "Debentures"); and (ii) five year Series A common stock purchase warrants (the “Series A Warrants”) representing the right to acquire up to 863,365 shares of our Class A common stock (the “Offering”) in a transaction exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"), in reliance on the exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act. The Offering includes (i) $2,000,000 of Debentures and Series A Warrants pursuant to the exercise of  a green shoe (“Green Shoe”) provision contained in the transaction documents for the purchase and sale of the Prior Debentures (as defined below) and (ii) $3,180,157.78  of additional Debentures. The Debentures and Series A Warrants are being sold for a combination of cash and the cancellation of debt or receivables.


The Debentures, which mature on April 21, 2020,  pay interest in cash at the rate of 12.5% per annum, payable quarterly on January 1, April 1, July 1 and October 1, beginning on January 1, 2018. Our obligations under the Debentures are secured pari-passu with the debentures previously issued in April 2017 (“Prior Debentures”). The Debentures are convertible at the option of the holder into shares of our Class A common stock (“Common Stock”) at an initial conversion price of $3.00 per share, subject to adjustment as hereinafter described.


The Debentures were issued in two series, Series A-1 Debentures (“A-1 Debentures”) and Series A-2 Debentures (“A-2 Debentures”). The Company will issue (i) $2,000,000 in A-1 Debentures and (ii) $3,180,157.78 in A-2 Debentures. The A-1 Debentures and A-2 Debentures are substantially the same except that the A-1 Debentures (i) we approved for issuance on June 23, 2017 by the shareholders of the Company pursuant to the Green Shoe and (ii) have a conversion price floor of $1.40 with regard to anti-dilution protection for subsequent equity sales at a price lower than 120% of the then  applicable conversion price. The A-2 Debentures have a conversion price floor of $3.00 until such time as the Company receives shareholder approval for the transaction. On December 29, 2007, at our annual meeting of shareholders, we obtained approval of the transaction including the $1.40 floor price of the A-2 Debentures in the event of subsequent equity sales.




22



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Subject to our compliance with certain equity conditions (as more fully set forth in the Debentures), upon 20 trading days' notice to the holders we have the right to redeem the Debentures in cash at a 120% premium during the first year and a 110% premium during the remaining term of the Debentures. Upon any optional redemption, we are obligated to issue the holder Series B Common warrants, the terms of which will be identical to the Series A Warrants, to purchase a number of shares of our Common Stock equal to 50% of the conversion shares issuable on an as-converted basis as if the principal amount of the Debenture had been converted immediately prior to the optional redemption. In the event of future financings by us, subject to certain exempt issuances, the holders have the right to cause us to allocate 20% of the proceeds we receive to redeem a portion of the principal amount of the then outstanding Debentures. We are also required to redeem the Debentures, at the holder’s right, upon our failure to maintain certain financial covenants as further described in the Debentures.


The Debentures also contain certain customary events of default (including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, changes in control of the Company and the entering or filing of certain monetary judgments against the Company). Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture  for a premium , plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the holder’s election, immediately due and payable in cash. The Company is also subject to certain negative covenants under the Debenture, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends.


The Series A Warrants are being issued as follows: (i) 333,335 issued pursuant to the Green Shoe and in connection with  A-1 Debentures and (ii) 530,030 are being issued in connection with  the A-2 Debentures. The Series A Warrants issued pursuant to the A-1 Debentures and A-2 Debentures have the same form . The Series A Warrants are initially exercisable at $3.00 per share and, are subject to cashless exercise after six months if the shares underlying the warrants are not subject to an effective resale registration statement.  The Series A Warrants also contain anti-dilution protection for subsequent equity sales for a price lower than the then applicable exercise price, with a floor of $1.40.


The conversion price of the Debentures and the exercise price of the Series A Warrants are subject to adjustments upon certain events, including stock splits, stock dividends, subsequent equity transactions (other than specified exempt issuances), subsequent rights offerings, and fundamental transactions, subject to the $1.40 and $3.00 floor described above). If we fail to timely deliver the shares of our Common Stock upon any conversion of the Debentures or exercise of the Series A Warrants, we will be subject to certain buy-in provisions. Pursuant to the terms of the Debentures and Series A Warrants, a holder will not have the right to convert any portion of the Debentures or exercise any portion of the Series A Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Series A Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61 st  day after such notice is delivered from the holder to the Company.


The Company also agreed to use up to approximately $1.57 million in proceeds from the Offering to pay a $1.5 million put obligation of the outstanding Financing Warrant plus $.07 million in accrued interest on the amount outstanding.


As of the date of the Securities Purchase Agreement, the Company had 8,605,018 shares of Common Stock issued and outstanding. As such, under the Nasdaq Market Place Rules, we are authorized to issue up to 19.99% of the issued and outstanding shares, or 1,720,143 shares.  The shares of Common Stock underlying the A-2 Debentures and accompanying Series A Warrants are an aggregate of 1,590,081 shares of  Common  Stock. Notwithstanding, we are obligated to submit the Offering at the Shareholder Meeting for the purpose  of reducing the floor  conversion price of the A-2 Debentures as discussed above. In connection with this transaction, we will  issue to  our Placement Agents (as defined below), an aggregate of 183,337 common stock purchase warrants (“PA Warrants”) as follows: (i) 129,176 PA Warrants will have an exercise price of $3.75 per share and (ii)  54,161  PA Warrants will have an exercise price of $4.49 (the consolidated closing bid price of the Common Stock  prior to the Securities Purchase Agreement). The PA Warrants are substantially similar to the Series A Warrants, except that the PA Warrants have a term of five and one half (5.5) years, are not  exercisable  until the six (6) month anniversary of the issuance date, and contain no anti-dilution protection.




23



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Pursuant to a registration rights agreement (“Registration Rights Agreement”), we have agreed to file a registration statement registering the resale of the shares of our common Stock underlying the Debentures and the Series A warrants within thirty (30) days from the date of the Registration Rights Agreement. We also agreed to have the registration statement declared effective within 90 days from the date of the Registration Rights Agreement and keep the registration statement continuously effective until the earlier of (i) the date after which all of the securities to be registered thereunder have been sold, or (ii) the date on which all the securities to be registered thereunder may be sold without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 under the Securities Act. We are also obligated to pay the Investors, as partial liquidated damages, a fee of 2.0% of each Investor’s subscription amount per month in cash upon the occurrence of certain events, including our failure to file and  or have the registration statement declared effective within the time periods provided.  As a result of the registration statement not being declared effective, we have accrued partial liquidated damages of $103,862.16 as of April 30, 2018 (including interest accruing at 18% per annum).  We will continue to incur additional liquidated damages on a monthly basis in the event that the registration statement is not declared effective.


Chardan Capital Markets, LLC (“Chardan Capital”) acted as lead placement agent and Aspenwood Capital acted as co-placement agent ("Aspenwood"), in connection with the sale of the securities pursuant to the Securities Purchase Agreement. Pursuant to their respective engagement agreements , we will pay Chardan Capital a cash commission of $149,021.25 and Aspenwood a cash commission of $70,000. Pursuant to the discussion above, we also issued an aggregate of 160,000 PA Warrants to Chardan Capital and an aggregate of 23,337 PA Warrants to Aspenwood. We will include the shares underlying the Placement Agent Warrants in the resale registration statement we expect to file.

 

Convertible Notes


During the year ended December 31, 2017, certain holders of convertible debentures exercised their rights to convert amounts of principal totaling $3,335,000 into 1,111,667 shares of the Company’s common equity. During the three month period ended March 31, 2018, the Company made no repayments on secured convertible debentures.


During the three month period ended March 31, 2018, the Company recorded interest expense on the convertible debentures totaling $330,952.  During the three month period ended March 31, 2018, the Company also recognized $332,658 of amortization of debt discount and deferred financing costs.


Future minimum principal payments under senior secured convertible notes as of March 31, 2018, were as follows:

 

 

 

Convertible

 

Year Ending December 31,

 

Notes

 

2018

 

$

 

2019

 

 

 

2020

 

 

6,845,157

 

Total minimum principal payments

 

 

6,845,157

 

Less: debt discount and deferred debt issuance costs

 

 

(4,801,353

)

Convertible notes, net

 

$

2,043,804

 




24



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


NOTE 11 – STOCKHOLDERS' EQUITY


Common Stock


On January 4, 2017, the Company entered a definitive securities purchase agreement with two fundamental institutional investors (the “Investors”) for the purchase and sale of an aggregate of: (i) 761,905 shares of the Company’s Class A common stock; and (ii) five-year Series B Warrants (the “Series B Warrants”) representing the right to acquire up an additional 380,953 shares of our Class A common stock at an exercise price of $7.00 per share. The shares of our Class A common stock and the Series B Warrants were sold in a registered direct offering and we received gross proceeds of $3,980,001. Simultaneously we conducted a private placement with the same Investors for no additional consideration of Series A Warrants (the “Series A Warrants”) representing the right to acquire up to an additional 380,953 shares of our Class A common stock at an exercise price of $6.70 per share. The Series A Warrants are exercisable for five years commencing 6 months from the date of closing of the private sale of the Series A Warrants to the Investors.


The exercise price of the Series A Warrants is subject to full ratchet adjustment in certain circumstances, subject to a floor price of $1.20 per share. The adjustment provisions under the terms of the Series A Warrants will be extinguished at such time as our Class A common stock trades at or above $10.00 per share for 20 consecutive trading days, subject to the satisfaction of certain equity conditions. In addition, if there is no effective registration statement covering the shares issuable upon the exercise of the Series A Warrants, the warrants are exercisable on a cashless basis. If we fail to timely deliver the shares underlying the warrants, we will be subject to certain buy-in provisions. As a result of the sale of the Debentures, the exercise price of the Series A Warrants issued to investors in our January 2017 private offering were reset to $2.245 per share.


Beginning 100 days after the issuance date of the Series B Warrants, at any time the market price of our Class A common stock is less than $5.25 per share, the holders had the right to exercise the Series B Warrants on a cashless basis for shares of our Class A common stock calculated pursuant to a formula set forth in the Series B Warrants. We had the right, in lieu of delivery of such shares of our Class A common stock, to pay the holder of the Series B Warrants being exercised on a cashless basis, a specified amount in cash, with a maximum cash payment of $2,500,000. The holders of the Series B Warrants exercised their right in April 2017 and we repurchased the Series B Warrants for $2,500,000.


Pursuant to the terms of the warrants, a holder of a warrant will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 9.99% of the number of shares of Class A common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased or decreased to any other percentage, not to exceed 9.99%; provided that any increase will not be effective until the 61 st  day after such notice is delivered from the holder to the Company.

 

In the event of any extraordinary transaction, as described in the warrants and generally including any merger with or into another entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our common stock, the holder will have the right to have the warrants and all obligations and rights thereunder assumed by the successor or acquiring corporation. Also, at the election of the holder of each warrant, in the event of an extraordinary transaction, we or any successor entity may be required to repurchase such warrant for an amount of cash equal to the value of the warrant as determined in accordance with the Black Scholes option pricing model and the terms of the warrants.


Pursuant to an engagement letter dated December 29, 2016 (the “Placement Agent Agreement”) by and between the Company and Chardan Capital Markets, Chardan Capital agreed to act as the Company’s placement agent in connection with both the registered direct offering and a concurrent private placement. Pursuant to the Placement Agent Agreement, the Company paid Chardan Capital a cash fee equal to $160,000 (4% of the gross proceeds), as well as reimbursement of its expenses related to the offering in the amount of $15,000. In addition, the Company granted Chardan Capital a warrant to purchase 76,190 shares of Class A common stock (the “Placement Warrants”). The Placement Warrants have an exercise price of $6.50 per share and are exercisable for 5.5 years commencing six months from the issuance date. The shares underlying the Placement Warrants were included in a resale registration statement on Form S-3 that was declared effective by the SEC in June 2017.




25



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


The net proceeds to the Company from the offering, after deducting placement agent fees and estimated offering expenses, were $3,830,000. The proceeds of the offering were used to satisfy the outstanding notes issued under the terms of the Financing Agreement. In connection with the January 2017 capital raise, Victory Park Management, LLC agreed not to exercise the put right under the Financing Warrant prior to May 20, 2017. Victory Park Management, LLC exercised the put right on May 22, 2017. We had had 45 days to satisfy this obligation which remains unpaid. On October 27, 2017, the Company satisfied this obligation in full utilizing a portion of net proceeds from a second debenture financing.


The Class A shares of common stock and Series B Warrants were sold and issued pursuant to the Prospectus Supplement, dated January 4, 2017, to the Prospectus included in the Company’s Registration Statement on Form S-3 (Registration No. 333-214644) filed with the SEC on November 16, 2016 and declared effective on November 28, 2016.


In January 2017, in connection with an advisory agreement with kathy ireland Worldwide LLC ("kiWW"), the Company issued affiliates and designees of kiWW 100,000 shares of its Class A common stock valued at $678,000


In January 2017, we issued 3,858 shares of our Class A common stock valued at $12,500 to Mr. Derek J. Ferguson upon his appointment to our board of directors and the audit committee of the board. He is an accredited investor and the issuance was exempt from registration under the Securities Act pursuant to an exemption provided by Section 4(a)(2) of that act.


In February 2017, the Company issued Mr. Steven Antebi 150,000 shares of our Class A common stock valued at $540,000 as compensation for services under the terms of a consulting agreement. He is a principal stockholder of the Company.


In March 2017, we issued 51,667 shares of Class A common stock for vested stock awards.


In March 2017, we issued 6,510 shares of our Class A common stock valued at $12,500 to Mr. Robert Jordan upon his appointment to our board of directors and the audit committee of the board. He is an accredited investor and the issuance was exempt from registration under the Securities Act pursuant to an exemption provided by Section 4(a)(2) of that act.


In August 2017, we issued 200,000 shares in conjunction with our acquisition of certain intellectual property assets from Leapfrog Media Trading, Inc.


On September 15, 2017, the Company entered an Investor Relations and Consulting Agreement (“Consulting Agreement”) with Al & J Media, Inc. (“Consultant”). The Company engaged the Consultant to provide certain consulting services on behalf of the Company as are more fully described in the Consulting Agreement. Under the terms of this agreement, which expires on December 15, 2017, the Company engaged Al & J Media, Inc. to provide a variety of advisory and consulting services to the Company, including introducing the Company to potential sources of media, marketing agreement(s) and/or other strategic alliances which may benefit the Company in the performance of implementing its business plan(s), including but not limited to radio and television media spots; various media publications; and internet podcasts. As compensation for such services, the Company issued Al & J Media, Inc. 75,000 shares valued at $97,500 of its Class A common stock on September 15, 2017.


Between September 2017 and January 2018, we issued an aggregate of 225,000 shares of Class A common stock valued at $1,137,650 as consideration for media and marketing services.


In October 2017, we issued 70,409 shares of our Class A common stock to Joseph P. Hannan, our chief financial officer, pursuant to his October 2017 employment agreement. The shares were issued pursuant to our 2016 equity compensation plan.




26



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


In October 2017, we entered into securities purchase agreements to sell an aggregate of $5,180,158 of our 12.5% secured convertible debentures and issued 863,365 Series A Common Stock Purchase Warrants. The debentures mature on 4/21/2020, bear interest at an annual rate of 12.5%, payable quarterly on January 1, April 1, July 1, and October 1, beginning on January 1, 2018. Pursuant to the greenshoe provision contained in our April 2017 debenture offering, $2,000,000 of debentures were purchased pursuant to the greenshoe provision and the remaining $3,180,157.78 were purchased separately. Of the 863,365 warrants issued, a total of 333,335 were purchased pursuant to the greenshoe provision and 630,030 were purchased separately. The debentures are convertible into shares of our Class A common stock at $3.00 per share, subject to adjustment, and contain anti-dilution protection for subsequent financings and have a conversion price floor of $1.40 per share (pursuant to shareholder vote approving the offering that occurred on December 29, 2017). The warrants have an exercise price of $3.00 per share, subject to adjustment and contain anti-dilution protection for subsequent financings and have an exercise price floor of $1.40 per share. In connection with the offering we issued Chardan Capital Markets 160,000 placement agent warrants, of which: (i) 129,176 have an exercise price of $3.75 and (ii) 54,161 have an exercise price of $4.49 (. We also issued Aspenwood Capital 23,337 placement agent warrants with an exercise price of $3.75. All placement agent warrants have a term of five and a half years (exercisable beginning 6 months after issuance).


In October 2017, multiple investors in the Company’s April 2017 debenture financing converted an aggregate of $655,000 of debentures into 218,334 shares of Class A common stock.


In October 2017, one investor in the Company’s April 2017 debenture financing exercised 83,334 Series A common stock purchase warrants at an exercise price of $3.00 per share, resulting in gross proceeds to the Company of $250,002.


In January 2018, we issued Colleen DiClaudio, a board member, 7,813 Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares were issued from our 2016 equity compensation plan


In January 2018, we issued Hardy Thomas, a former board member, 7,195 Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares were issued from our 2016 equity compensation plan.


In January 2018, we issued Marc Savas and Malcolm CasSelle each 3,774 Class A common shares valued at $10,000 as payment for their respective 2017 service on our board of directors. The shares were issued from our 2016 equity compensation plan.


In January 2018, we issued Al & J Media an additional 150,000 shares for media consulting services pursuant to an extension of their September 2017 Consulting Agreement.


In March 2018, we issued 6,667 shares of Class A common stock to one employee for vested stock awards.


In March 2018, 122,950 shares of Class A common stock were awarded to one employee for sales performance achievement pursuant to our 2016 equity compensation plan.


As of March 31, 2018, we have accrued as issuable to William Packer 3,774 shares of Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares will be issued from our 2016 equity compensation plan.


Stock Awards


During the three months ended March 31, 2018 and 2017, respectively, there were no new grants of stock awards made nor were any previously issued grants forfeited.


During the three months ended March 31, 2018 and 2017, we recorded stock award expenses of $52,189 and $144,848; respectively.




27



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Stock Options and Warrants


In November 2016, the Company entered an Investor Relations and Consulting Agreement (“Consulting Agreement”) with Market Street Investor Relations, LLC (“Consultant”). The Company engaged the Consultant to provide certain investor relations and public relations services on behalf of the Company as are more fully described in the Consulting Agreement. The term of the Consulting Agreement is for a period of six-months from the effective date and may be extended for an additional six-month term. In lieu of cash payments for the services rendered by the Consultant, the Company issued the Consultant a three year Class A common stock purchase warrant to purchase 400,000 shares of the Company’s Class A common stock at an exercise price of $7.50 per share. The warrants vest based on specific milestones described within the Consulting Agreement. The value of the warrants at the date of grant was $1,390,264. At the direction of the Consultant, a warrant to purchase 200,000 shares was issued to the Consultant and a warrant to purchase 200,000 shares was issued to Steve Antebi (a principal stockholder in the Company). The Company also advanced the Consultant $100,000 on the effective date to cover anticipated expenses regarding the services to be performed by the Consultant. The Company paid the Consultant an additional $50,000 for expenses incurred during the nine months ended September 30, 2017. The Company is recognizing the value of the services rendered over the term of the Consulting Agreement. As of September 30, 2017, the Consultant had not yet attained any of the milestones contained within the Consulting Agreement and the Company reversed $275,637 of expense related to the Consulting Agreement. It was then determined that the Company would not extend the Consulting Agreement with the Consultant.


During the three months ended March 31, 2017, an aggregate of 662,773 Common Stock purchase warrants, having exercise prices of between $5.00 and $10.00, per share, expired.


On January 24, 2018, 176,400 Common Stock purchase warrants, having exercise prices of $7.50, per share, expired.


During the three months ended March 31, 2018 and 2017, we recorded stock option expense of $83,941 and $33,419, respectively.


Reverse Stock Split


In September 2016, the Company completed a reverse stock split whereby each five shares of the Company's Class A common stock issued and outstanding, or held as treasury shares, immediately prior to the effective date of the reverse stock split became one share of its Class A common stock on the effective date of the reverse stock split. No fractional shares of Class A common stock were issued to any stockholder and all fractional shares which might otherwise be issuable because of the reverse stock split were rounded up to the nearest whole share. On the effective date of the reverse stock split, all outstanding options and warrants to purchase shares of the Company's Class A common stock were proportionally adjusted based upon the split ratio and became exercisable into one-fifth of the number of shares of the Company's Class A common stock as it was prior to the reverse stock split at an exercise price which is five times the exercise price prior to the reverse stock split.


After the effective date of the reverse stock split, each certificate representing shares of pre-reverse stock split Class A common stock was deemed to represent one-fifth of a share of the post-reverse stock split Class A common stock, subject to rounding for fractional shares, and the records of the Company's transfer agent, Transfer Online, Inc., were adjusted to give effect to the reverse stock split. Following the effective date of the reverse stock split, the share certificates representing the pre-reverse stock split Class A common stock continue to be valid for the appropriate number of shares of post-reverse stock split Class A common stock, adjusted for rounding.


These unaudited condensed consolidated financial statements give retroactive effect to the reverse stock split for all periods presented, unless otherwise specified.



28



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


NOTE 12 – RELATED PARTY TRANSACTIONS


On March 20, 2018, as we began to formally review potential strategic options for SRAXMD, we entered into certain retention and bonus agreements with  SRAXMD employees, including Erin DeRuggiero, our chief innovations officer. Pursuant to the terms of the agreements with Ms. DeRuggiero, her employment agreement was terminated, and she became a consultant of the Company. The term of the consultancy expires in the second quarter of 2018, or upon the sale of the assets comprising SRAXmd, but may be extended by the parties. The terms of the consultancy are substantially similar to her prior employment agreement except that in the event of a sale of the SRAXmd business unit or substantially all of the assets thereof within 120 days from March 20, 2018, (i) we (or our assignee) have the right and the obligation to purchase all of Ms. DeRuggiero’s outstanding Class A common shares (514,667) at a price of $5.80 per share, or an aggregate of $2,985,069 and (ii) we will pay Ms. DeRuggiero, an amount equal to five percent (5%) of the cash consideration received from the sale of the SRAXmd business. The Company and Ms. DeRuggiero agreed to a customary release from any claims that may have arisen during her employment.


On April 2, 2018, we issued a common stock purchase warrant to Kristoffer Nelson, our Chief Operating Officer and a member of our board of directors. The option entitles Mr. Nelson to purchase 100,000 shares of Class A Common Stock at a price per share of $5.78, has a term of three years and vests quarterly over a three (3) year period.


NOTE 13 – COMMITMENTS AND CONTINGENCIES


Operating Leases


The Company leases offices under operating leases that have expired and now operate on a month-to-month basis, subject to certain notice of termination provisions. Future minimum lease payments required under the operating leases amount to $50,636 for the year ended December 31, 2018.


Rent expense for office space amounted to $68,070 and $40,212 for the three month period ended March 31, 2018 and 2017, respectively.


Other Commitments


In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company's breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise due to their status or service as directors, officers or employees. The Company has also agreed to indemnify certain former officers, directors and employees of acquired companies in connection with the acquisition of such companies. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors and employees of acquired companies, in certain circumstances.


It is not possible to determine the maximum potential amount of exposure under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each agreement. Such indemnification agreements may not be subject to maximum loss clauses.


Employment agreements


We have entered employment agreements with key employees. These agreements may include provisions for base salary, guaranteed and discretionary bonuses and option grants. The agreements may contain severance provisions if the employees are terminated without cause, as defined in the agreements.




29



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 


Litigation


From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. In addition, the Company may receive letters alleging infringement of patent or other intellectual property rights. The Company is not currently a party to any material legal proceedings, nor is the Company aware of any pending or threatened litigation that would have a material adverse effect on the Company's business, operating results, cash flows or financial condition should such litigation be resolved unfavorably.


NOTE 14 – FAIR VALUE OF FINANCIAL INSTRUMENTS


The carrying amounts of certain financial instruments, including cash and cash equivalents, restricted cash and accounts payable, approximate their respective fair values due to the short-term nature of such instruments.


The fair value of the 2017 Senior Secured Convertible Notes was $6,845,257 as of March 31, 2018. The fair value of the Convertible Notes was $6,845,257 as of December 31, 2017. All Convertible Notes fall within Level 3 of the fair value hierarchy as their value is based on the credit worthiness of the Company, which is an unobservable input. The Company used a Tsiveriotis - Fernandes model to value the 2017 Senior Convertible Notes as of March 31, 2018.

 

Assets and Liabilities Measured at Fair Value on a Recurring Basis

 

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The following table summarizes the conclusions reached regarding fair value measurements as of March 31, 2018 and December 31, 2017:

 

 

 

 

 

 

Quoted Prices in Active Markets

 

 

Significant Other

 

 

Significant

 

 

 

Balance as of

 

 

for

 

 

Observable

 

 

Unobservable

 

 

 

March 31,

 

 

Identical Assets

 

 

Inputs

 

 

Inputs

 

 

 

2018

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Put Warrant liability

 

$

 

 

$

 

 

$

 

 

$

 

Embedded Warrant Put Option

 

 

 

 

 

 

 

 

 

 

 

 

Embedded Derivatives in Convertible Notes

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

$

 

 

$

 

 

$

 

 

$

 

Securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit

 

 

 

 

 

 

 

 

 

 

 

 

Money Market funds

 

 

189,888

 

 

 

189,888

 

 

 

 

 

 

 

U.S. government-sponsored agency securities

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

189,888

 

 

$

189,888

 

 

$

 

 

$

 




30



SOCIAL REALITY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTH PERIOD ENDED MARCH 31, 2018 AND 2017

(Unaudited)

 



 

 

 

 

 

Quoted Prices in Active Markets

 

 

Significant Other

 

 

Significant

 

 

 

Balance as of

 

 

for

 

 

Observable

 

 

Unobservable

 

 

 

December 31,

 

 

Identical Assets

 

 

Inputs

 

 

Inputs

 

 

 

2017

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Put Option Liability

 

$

 

 

$

 

 

$

 

 

$

 

Contingent Consideration

 

 

 

 

 

 

 

 

 

 

 

 

Embedded Warrant Put Option

 

 

 

 

 

 

 

 

 

 

 

 

Embedded Derivatives

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

$

 

 

$

 

 

$

 

 

$

 

Securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit

 

 

 

 

 

 

 

 

 

 

 

 

Money Market Funds

 

 

1,017,299

 

 

 

1,017,299

 

 

 

 

 

 

 

U.S. government-sponsored agency securities

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

1,017,299

 

 

$

1,017,299

 

 

$

 

 

$

 

 

The Company’s Warrant liability, embedded Warrant Put Option and the contingent consideration payments as well as the securities are measured at fair value on a recurring basis. As of March 31, 2018 and December 31, 2017, the Underwriter Warrant liability, Deerfield Warrant liability, embedded Warrant Put Option and the fundamental change and make-whole interest provisions embedded in the 2021 Notes are reported on the balance sheets in derivative and warrant liability, while the trading securities are reported on the balance sheets in marketable securities and long-term investments. As of December 31, 2016, the embedded Put Option is reported on the balance sheet in derivative and warrant liability. The Company used the settlement value for liability, the Put Option at December 31, 2016. The outstanding put option at December 31, 2016 was settled in January 2017. The Company incurred a warrant put option liability as a result of warrants issued in the January 2017 equity financing. This warrant put option liability was settled in April 2017 as it fair value of $2.5 million. Changes in the fair value of the Put Option liability in the 2016 was reflected in the statements of operations as a change in value adjustment.

 

A reconciliation of the beginning and ending balances for the derivative and warrant liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is as follows (in thousands):

 

 

 

March 31,

2018

 

 

December 31,

2017

 

Balance as of beginning of period

 

$

 

 

$

1,500,000

 

Payments

 

 

 

 

 

 

Adjustment to fair value

 

 

 

 

 

 

Balance as of end of period

 

$

 

 

$

1,500,000

 

 

NOTE 15 – SUBSEQUENT EVENTS


None








31





ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.


The following discussion of our financial condition and results of operations for the three month periods ended March 31, 2018 and 2017 should be read in conjunction with the unaudited condensed consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements because of several factors, including those set forth under the Part I, Item 1A, Risk Factors, Cautionary Notice Regarding Forward-Looking Statements and Business sections in our Annual Report on Form 10-K for the year ended December 31, 2017, as amended in Form 10-K/A (Amendment No. 1), this report, and our other filings with the Securities and Exchange Commission. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, our anticipated growth and trends in our businesses, and other characterizations of future events or circumstances are forward-looking statements. Such statements are based on our current expectations and could be affected by the uncertainties and risk factors described throughout this report.


Overview


We are a digital marketing and data management platform delivering the tools to reach and reveal valuable audiences. Our machine-learning technology analyzes marketing data to identify brands and content owners' core consumers and their characteristics across marketing channels. Through an omnichannel approach that integrates all aspects of the advertising experience into one platform, we discover new and measurable opportunities that amplify campaign performance and maximize profits . We derive our revenues from:


·

sales of digital advertising campaigns to advertising agencies and brands;

·

sales of media inventory through real-time bidding, or “RTB”, exchanges;

·

sale and licensing of our SRAX Social platform and related media; and,

·

creation of custom platforms for buying media on SRAX for large brands.


The core elements of our business are:


·

Social Reality Ad Exchange or "SRAX" Real Time Bidding sell side and buy side representation is our technology which assists publishers in delivering their media inventory to the RTB exchanges. The SRAX platform integrates multiple market-leading demand sources, including OpenX, Pubmatic and AppNexus. We also build custom platforms that allow our agency partners to launch and manage their own RTB campaigns by enabling them to directly place advertising orders on the platform dashboard and view and analyze results as they occur;


·

SRAXmd serves ads to both Healthcare Professionals and Patients using patent-pending process and technology. Powerful first and third-party data allow us to reach more than 400,000 Healthcare Professionals and Patients with real-time ad targeting, serving banner and video ads to personal devices. Advertising agencies and pharmaceutical clients contract with us directly to secure ad space and to license the MOSEE ad targeting platform on an annual basis.


·

SRAX Social is a social media and loyalty platform that allows brands to launch and manage their social media initiatives. Our team works with customers to identify their needs and then helps them in the creation, deployment and management of their social media presence; and


·

SRAXfan tools enable brands and agencies to connect with sports fans at home, the stadium or out-of-home at gathering locations, such as bars, restaurants, and universities, during live sporting events.


·

SRAXauto tools enable targeting and engagement with potential auto buyers at dealerships, auto shows, and at home across desktop and mobile environments.


We offer our customers several pricing options including cost-per-thousand-impression, commonly referred to as CPM, whereby our customers pay based on the number of times the target audience is exposed to the advertisement, and on a monthly service fee.



32





During 2017, we launched a new SRAX Social tool for digital marketers and content owners to create posts and promote them beyond their respective Facebook Page communities. This tool is the first of many planned monetization opportunities to be developed and integrated into SRAX Social . We also released a new guide entitled “People-Based Advertising: How to Get Bigger Results by Targeting the Most Precise Audience” which we believe will provide support for our expertise as an Internet advertising resource. We also unveiled the Company’s new SRAX branding, designed to reflect the breadth and depth of the tools that we offer to digital marketers and content owners.


In 2017, we also announced several new product offerings designed to expand our reach for advertisers to other large digital audiences. SRAX Fan is a buyside vertical focused on advertising to sports fans on their mobile devices in stadiums and sports bars. SRAX Auto is another new buyside vertical launched to target car buyers. While SRAX Fan and SRAX Auto have formally launched, they remain very early stage. As such, we do not believe these two new initiatives will be significant contributors to revenue growth for the remainder of 2018.


In late 2017, we also announced the launch of the BIGToken project. Presently we are developing BIGToken as a wholly owned subsidiary of Social Reality and eventually anticipate spinning the company out to our shareholders. In March of 2018, we announced the Alpha launch of the BIG platform to a select group of individuals and entities. Users participating in our BIGToken Alpha will be able to create an account, integrate third party accounts and answer serves in order to create an initial data graph. Participants in the Alpha will be awarded points as opposed to a BIGToken. Although the Alpha launch was a major milestone for the BIGToken project, there can be no assurance that we will complete final development of the BIGToken project or if developed, that it will be successful.


At present, we anticipate commencing a closed Beta of the BIGToken platform during the second quarterly of 2018 and then commencing an open Beta during the third quarter of 2018 with the BIGToken platform becoming generally available in early 2019. Notwithstanding the foregoing anticipated development dates, to fully launch BIGToken, not only will we be required to complete development and testing of the platform, but we will also need to comply with both state and federal securities laws and regulations with regard to certain aspects of the platform. There can be no assurances that we will be able to comply with such laws or regulations on a timely basis, if at all. Our failure to adequately comply with such laws and regulations, or comply with them on a timely basis, will greatly impact the value and utility of the BIGToken platform.


Results of operations


Selected Consolidated Financial Data


 

 

Three Months Ended March 31,

 

 

 

2018

 

 

2017

 

 

change

 

 

 

(unaudited)

 

 

 

 

 

 

 

Revenue

 

$

2,110,850

 

 

 

5,326,163

 

 

 

-60.4

%

Cost of revenue

 

 

818,105

 

 

 

3,279,120

 

 

 

-75.1

%

Gross margin percentage

 

 

61.2

%

 

 

38.4

%

 

 

59.3

%

Operating expense, net

 

 

4,130,258

 

 

 

5,256,519

 

 

 

-21.4

%

Operating loss

 

 

(2,837,513

)

 

 

(3,209,476

)

 

 

-11.6

%

Other income (expense)

 

 

(772,107

)

 

 

(711,446

 

 

8.5

%

Net loss

 

$

(3,609,620

)

 

 

(3,920,922

)

 

 

7.9

%


Revenue


The decrease in our revenue during the three months ended March 31, 2018 from the comparable period in 2017 reflect our strategic shift that began in 2017 to focus on higher margin revenue opportunities from buy-side clients as well as decreases in revenue from our SRAXReach product. These revenue declines were partially offset by an increase in revenue from our SRAXmd clients.


Cost of revenue


Cost of revenue consists of certain labor costs, payments to website publishers and others that are directly related to a revenue-generating event and project and application design costs. Approximately 100% of cost of revenue was attributable to payments to website publishers and other media providers for the first three months 2018 as compared to 100% during the first three months of 2017. Cost of revenue as a percentage of revenue declined to 38.8% for the first quarter of 2018 from 61.6% for the three months ended March 31, 2017. Cost of revenue declined in the first quarter of 2018 due to a strategic shift made by management in the prior year to focus sale efforts on advertising business with substantially higher gross margins.



33





Operating expense


Our operating expenses are comprised of salaries, commissions, marketing and general overhead expenses. Overall, our net operating expense decreased 21.4% in the first quarter of 2018 from the comparable period in 2017. Since our expense restructuring program was instituted at the end of the first quarter 2017, we expect that our operating expenses will continue to be flat to slightly higher for the remainder of 2018 as we make additional expense investments necessary to expand our new revenue initiatives.


Other income (expense)


Other income (expense) in the first quarter of 2018 represents factoring fees represents interest due on convertible debentures, factoring fees, and amortization of deferred debt issuance costs. Total interest expense increased 7.9% for the three month period ended March 31, 2018 as compared to the same period in 2017. We expect that our overall interest expense during the balance of 2018 will continue to decease as a result of lower carrying levels of 12.5% secured convertible debentures resulting from conversions that occurred in the third and fourth quarter of 2017.


Non-GAAP financial measures


We use Adjusted net loss to measure our overall results because we believe it better reflects our net results by excluding the impact of non-cash equity based compensation and the accretion of put warrants. We use Adjusted Earnings before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”) to measure our operations by excluding interest and certain additional one-time expenses. We believe the presentation of Adjusted net loss and Adjusted EBITDA enhances our investors' overall understanding of the financial performance of our business.


You should not consider Adjusted net loss and Adjusted EBITDA as an alternative to net loss, determined in accordance with GAAP, as an indicator of operating performance. A directly comparable GAAP measure to Adjusted net loss and Adjusted EBITDA is net loss.


The following is a reconciliation of net loss to Adjusted net loss and Adjusted EBITDA for the periods presented:


 

 

For the

Three Month Period Ended

March 31,

 

 

 

2018

 

 

2017

 

Net Loss

 

$

(3,609,620

)

 

$

(3,920,922

)

plus

 

 

 

 

 

 

 

 

Equity Based compensation

 

 

166,130

 

 

 

512,442

 

Accretion of put liability

 

 

 

 

 

 

Adjusted net loss

 

$

(3,443,490

)

 

$

(3,408,480

)

Restructuring Costs

 

 

 

 

 

377,961

 

Write-off of non-compete agreement

 

 

 

 

 

468,751

 

Exchange Gain or Loss

 

 

4,664

 

 

 

 

Interest Expense

 

 

767,443

 

 

 

711,446

 

Depreciation and amortization

 

 

175,625

 

 

 

110,954

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

$

(2,495,758

)

 

$

(1,739,368

)


Liquidity and capital resources


Liquidity is the ability of a company to generate sufficient cash to satisfy its needs for cash. Our primary need for liquidity is to fund working capital requirements of our business and other general corporate purposes, including debt repayment. At March 31, 2018, we had an accumulated deficit of $24,758,326. As of March 31, 2018, we had $189,888 in cash and cash equivalents and a net working capital deficit of $1,917,197 as compared to $1,017,299 in cash and cash equivalents and net working capital of $1,124,023 at December 31, 2017. We are currently experiencing a period of limited liquidity resulting from the complete repayment of notes associated with a financing agreement previously held by Victory Park Management, LLC, the repurchase of the Series B Warrants in April 2017, and the satisfaction of amounts due under the Financing Warrant (as defined in Note 8 of the footnotes to the Financial Statements).




34





During the third quarter of 2017 we launched the BigToken project. To date, we have not segregated the costs and expenses of BigToken from our other operating expenses. We estimate that we have incurred an aggregate of approximately $491,530 of operating expenses related to this project as of March 31, 2018. In addition, we have capitalized software development costs of $51,922 related to BigToken, as of March 31, 2018. We anticipate that BigToken will be financed independently from Social Reality through the sale of the subsidiary’s equity, debt, or equity-linked securities. Based on our current development plans, and assuming there is no revenue for the first twelve months, we estimate that BigToken will require approximately $5 million and $15 million for the initial and subsequent 12-month periods of operations, respectively, provided however that such capital requirements may increase or decrease based on the speed of development, user adoption rates and revenues. In the event that BigToken is not able to secure independent funding, we may nonetheless continue to develop the BigToken project internally albeit on a reduced scope and extended time frame. In such instance, we do not believe the project will initially result in a material increase to our operating expenses as the majority of BigToken’s initial expenses are either duplicative administrative expenses or related to customer acquisition once the platform is successfully launched.


As previously disclosed in October 2017, we engaged outside advisors to review strategic alternatives for SRAXmd. As a result, in late 2017, we commenced an auction process with regard to the SRAXmd assets. We believe that we are now entering the final stage of the auction process. Although management is optimistic regarding the successful completion of the auction process, there can be no assurances that the process will be completed, will be successful, or that if such process is completed, that it will be on terms favorable to us.


During January 2017, we satisfied all outstanding obligations under a financing agreement utilizing proceeds from the factoring of our receivables and sales of our securities. The repayment of these notes has adversely impacted our current liquidity. To address the immediate impact of this decreased liquidity, we developed certain operating plans that focus on increased revenue growth and cost reductions as further described herein. During April 2017, we raised $5,000,000 through the sale of 12.5% convertible debentures. We utilized $2,500,000 of the proceeds of this sale to satisfy the put obligation of the Series B Warrants issued to investors in the January 2017 offering. The balance of the debenture sales proceeds was used to satisfy the payment of accounts payable and other working capital requirements. During October 2017, we raised an additional $5,180,157 through the sale of similar 12.5% convertible debentures. We utilized $1,567,612 of the proceeds of this sale to satisfy obligations due under the Financing Warrant. The balance of the October 2017 debenture sales proceeds were also used to satisfy the payment of accounts payable and other working capital requirements.


As described in Part II, Item 1A- Risk Factors, the terms of both the April 2017 and October 2017 debentures could materially impact our liquidity and results of operations in future periods. If our revenue increases throughout the next twelve months as anticipated, additional liquidity is expected to be readily available under our accounts receivable factoring agreement with FastPay which is now subject to a cap of $4,000,000 that we agreed to as part of the debentures in April 2017.


Cash flows from operating activities


Net cash used in operating activities was $574,844 during the three months ended March 31, 2018 compared to net cash used in operating activities of $611,442 for the comparable period in 2017. During the three months ended March 31, 2018, the Company’s accounts receivable decreased by $2,614,247 from the accounts receivable balance at December 31, 2017. Accounts payable and accrued liabilities during the three months ended March 31, 2018 decreased by $178,022 from the period ending December 31, 2017.


Cash flows from investing activities


During the three months ended March 31, 2018 net cash used in investing activities was $252,567 as compared to $141,062 during the three months ended March 31, 2017. Our principal use of cash in investing activity is to acquire equipment and develop internally used software.


Cash flows from financing activities


During the three months ended March 31, 2018 net cash provided by financing activities was $0. During the comparable period in 2017, net cash in the amount of $176,927 was used in financing activities which primarily consisted of proceeds from the sale of common stock of $3,820,001 offset by a $3,996,928 repayment of notes payable.




35





Critical accounting policies


The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the reported periods. The more critical accounting estimates include estimates related to revenue recognition and accounts receivable allowances. We also have other key accounting policies, which involve the use of estimates, judgments and assumptions that are significant to understanding our results, which are described in Note 2 to our unaudited condensed consolidated financial statements appearing elsewhere in this report.


Recent accounting pronouncements


The recent accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.


Off balance sheet arrangements


As of the date of this report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term "off-balance sheet arrangement" generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with us is a party, under which we have any obligation arising under a guarantee contract, derivative instrument or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets.


ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.


Not applicable for a smaller reporting company.


ITEM 4.

CONTROLS AND PROCEDURES.


Evaluation of Disclosure Controls and Procedures . We maintain “disclosure controls and procedures” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934. In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Based on their evaluation as of the end of the period covered by this report, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were not effective to ensure that the information relating to our company, required to be disclosed in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure as a result of continuing material weaknesses in our internal control over financial reporting identified in our Annual Report on Form 10-K for the year ended December 31, 2017.


We continue to work toward full remediation of these material weaknesses. We expect that the remediation of these material weaknesses in our internal control over financial reporting will remediate the weakness in our disclosure controls and procedures.


Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.





36





PART II - OTHER INFORMATION


ITEM 1.

LEGAL PROCEEDINGS.


None


ITEM 1A.

RISK FACTORS.


In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2017 and our subsequent filings with the SEC, which could materially affect our business, financial condition or future results, subject to the new or modified risk factors appearing below that should be read in conjunction with the risk factors disclosed in such Form 10-K. These cautionary statements are to be used as a reference in connection with any forward-looking statements. The factors, risks and uncertainties identified in these cautionary statements are in addition to those contained in any other cautionary statements, written or oral, which may be made or otherwise addressed in connection with a forward-looking statement or contained in any of our subsequent filings with the SEC.


The terms of the Debentures could materially impact our liquidity and results of operations in future periods.


Certain terms of the Debentures that we issued in April 2017 and October 2017 could materially impact our liquidity and results of operations in future periods, including:


·

Interest on the Debentures is payable on a quarterly basis in cash at 12.5% per annum beginning July 1, 2017;

·

The Debentures are secured by a second position security interest in our accounts receivable, second only to FastPay, and a first position security interest in the balance of our assets, including our intellectual property;

·

We are subject to continued compliance with certain financial covenants, including a minimum monthly current ratio, a maximum quarterly corporate expense ratio, and minimum quarterly revenue and EBITDA related to SRAXmd ;

·

The Debentures are subject to a mandatory redemption by us;

·

In the event of future financings by us, subject to certain exempt issuances, the holders of the Debentures have the right to cause us to allocate 20% of the proceeds we may receive as a mandatory redemption of a portion of the principal amount then outstanding;

·

While we are able to redeem the Debentures in cash at a 120% premium during the first year and a 110% premium during the remaining term of the Debentures, our ability to undertake an optional redemption of the Debentures is subject to our compliance with certain equity conditions;

·

Our ability to incur additional indebtedness is limited, as is our ability to issue additional equity;

·

We have agreed to a cap of $4,000,000 on the sale of our accounts receivable to FastPay under the FastPay factoring agreement;


Our failure to conduct our business within the confines of these contractual restrictions could result in an event of default under the Debentures. The Debentures also contain various other events of default, among others, including failure to pay principal or interest, breach or misrepresentation of covenants, representations or warranties, filing of or proceedings for bankruptcy, ineligibility of listings or quotations on the trading market for our Class A common stock, a change in control of the Company, and the false or inaccurate certification regarding our compliance with any equity conditions.


Upon default, remedies range from notice and cure, to acceleration of both principal and interest. Our operations may not generate sufficient cash to enable us to service our debt. Upon an event of default under the debentures, if we were unable to cure the default within the prescribed periods, if at all, the holders could accelerate all amounts then due. If we were unable to repay these obligations, the holders could foreclose on our assets, in which case our ability to continue our business and operations as then conducted would be in jeopardy. If the holders should foreclose on our assets, it is likely you would lose your entire investment in our company. These obligations may further adversely impact our business and operations in other areas, including making it more difficult to satisfy our other obligations, increasing our vulnerability in the event of a downturn in our business prospects and limiting our flexibility to plan for, or react to, changes in our markets and possibly placing us at a competitive disadvantage when compared to our competitors who have less debt. We are currently in compliance with the provisions of the debt covenants and are current with our interest payments as of November 5, 2017.




37





Failure to meet the financial performance guidance or other forward-looking statements we have provided to the public could result in a decline in our stock price .


We have previously provided, and may provide in the future, public guidance on our expected financial results for future periods. Although we believe that this guidance provides investors with a better understanding of management's expectations for the future and is useful to our stockholders and potential stockholders, such guidance is comprised of forward-looking statements subject to the risks and uncertainties. Our actual results may not always be in line with or exceed the guidance we have provided. For example, we did not meet our 2017 revenue guidance. If our financial results for a particular period do not meet our guidance or if we reduce our guidance for future periods, the market price of our Class A common stock may decline.


Risks Related to the BIG Platform and BIGToken Project


There can be no assurance that BIGTokens will ever be issued.


The Company recently announced its intent to develop the BIGToken Platform as a means of securing higher quality user data. The Company anticipates that a material part of the platform will be the issuance of BIGTokens to users. There can be no assurance that it will do so. Should the Company fail to issue the BIGTokens, the attractiveness of the BIGToken Platform may be materially affected and we will not recognize the benefits of the project.


There is currently no trading market for BIGTokens, and a trading market may never develop.


If the BIGTokens are ultimately issued, there is currently no trading market available for the BIGTokens, no Designated Exchange, and peer-to-peer transfers will not be permitted unless and until holders are notified otherwise by the Company and informed of the requirements to and conditions to do so. As a result of recent regulatory developments, conventional crypto exchanges are currently unwilling to list securities tokens, such as the proposed BIGTokens. As a result, if and when issued and they become transferable, BIGTokens may only be tradable on very limited range of venues, including U.S. registered exchanges or regulated alternative trading systems for which a Form ATS has been properly submitted to the SEC. Currently, the Company is unaware of any operational ATS or exchange capable of supporting secondary trading in BIGTokens, if and when issued. Additionally, even if the BIGTokens are issued and become transferable, we may rely on technology, including smart contracts, to implement certain restrictions on transferability in accordance with federal or state securities laws. There can be no assurances that such technology will function properly, which could result in technological limitations on transferability and expose the Company to legal and regulatory issues. As a result of these technological, legal and regulatory considerations, a market for the BIGToken may never be developed and, if developed, may, for a variety of technological, legal and regulatory reasons, never become operational or efficient. In the event that a market for BIGTokens does not develop, the value of the BIGTokens would be materially adversely affected which could also have a materially adverse effect on our BIGToken Platform and the anticipated benefits therefrom.


Regulatory authorities may never permit a trading system to become operational on which BIGTokens could trade.


Numerous regulatory authorities, including FINRA and the SEC, would need to permit a trading system on which the BIGToken could trade to become operational. If FINRA, the SEC or any other regulatory authority objected to such system or exchange, such regulatory authorities could prevent the system or exchange from ever becoming operational. Any such regulatory issues would have a material adverse impact on our BIGToken Platform project.


The potential application of U.S. laws regarding investment securities to the tokens is unclear.

 

Securities, such as the BIGToken are novel and the application of U.S. federal and state securities laws is unclear in many respects. Because of the differences between securities such as the BIGToken and traditional investment securities, there is a risk that issues that might have easily been resolved by existing law if traditional securities were involved may not be easily resolved for securities such as BIGToken, if and when issued. In addition, because of the novel risks posed by securities such as BIGToken, it is possible that securities regulators may interpret laws in a manner that adversely effects their value. For example, if applicable securities laws restrict the ability for BIGTokens to be transferred, this would have a material adverse effect on the value of the BIGToken, which could result in a material impact on the BIG Platform project.




38





The regulatory regime governing blockchain technologies, cryptocurrencies, digital assets, and offerings of digital assets, such as the BIGToken, is uncertain, and new regulations or policies may materially adversely affect the development and the value of the BIG Platform.


Regulation of digital assets, like the anticipated BIGTokens, cryptocurrencies, blockchain technologies and cryptocurrency exchanges, (i) is currently undeveloped and likely to rapidly evolve as government agencies take greater interest in them, (ii) varies significantly among international, federal, state and local jurisdictions and (iii) is subject to significant uncertainty. Various legislative and executive bodies in the United States and in other countries may in the future adopt laws, regulations, or guidance, or take other actions, which may severely impact the permissibility of securities such as the BIGToken, tokens generally and, in each case, the technology behind them or the means of transaction in or transferring them. Our failure to comply with any laws, rules and regulations, some of which may not exist yet or that are subject to interpretations that may be subject to change, could result in a variety of adverse consequences, including civil penalties and fines.


Cryptocurrency networks, distributed ledger technologies, and coin and token offerings also face an uncertain regulatory landscape in many foreign jurisdictions such as the European Union, China and Russia. Various foreign jurisdictions may in the near future, adopt laws, regulations or directives that affect securities such as the proposed BIGToken. Such laws, regulations or directives may conflict with those of the United States or may directly and negatively impact our BIGToken Platform. The effect of any future regulatory change is impossible to predict, but such change could be substantial and materially adverse to the adoption and value of BIGTokens, when and if issued, and the financial performance of our BIGToken Platform, when and if developed.


The further development and acceptance of blockchain networks, which are part of a new and rapidly changing industry, are subject to a variety of factors that are difficult to evaluate. The slowing or stopping of the development or acceptance of blockchain networks and blockchain assets would have an adverse material effect on the successful development and adoption of BIGTokens.


The growth of the blockchain industry in general, as well as the blockchain networks on which the BIG Platform and BIGTokens will rely, are subject to a high degree of uncertainty. The factors affecting the further development of the cryptocurrency and cryptosecurity industry, as well as blockchain networks, include, without limitation:


·

worldwide growth in the adoption and use of cryptocurrencies, cryptosecurities and other blockchain technologies;

·

government and quasi-government regulation of cryptocurrencies, cryptosecurities and other blockchain assets and their use, or restrictions on or regulation of access to and operation of blockchain networks or similar systems;

·

the maintenance and development of the open-source software protocol of cryptocurrency or cryptosecurities networks;

·

changes in consumer demographics and public tastes and preferences;

·

the availability and popularity of other forms or methods of buying and selling goods and services, or trading assets including new means of using government-backed currencies or existing networks;

·

general economic conditions and the regulatory environment relating to cryptocurrencies and cryptosecurities; and

·

a decline in the popularity or acceptance of cryptocurrencies or other blockchain-based tokens would adversely affect BIGTokens, when and if issued, and have a materially adverse effect on the BIGToken Platform.


The cryptocurrency and cryptosecurities industries as a whole have been characterized by rapid changes and innovations and are constantly evolving. Although they have experienced significant growth in recent years, the slowing or stopping of the development, general acceptance and adoption and usage of blockchain networks and blockchain assets may deter or delay the acceptance and adoption of the tokens.


ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.


The following information is given with regard to unregistered securities sold since January 1, 2018. The following securities were issued in private offerings pursuant to the exemption from registration contained in the Securities Act of 1933, as amended (the “Securities Act”) and the rules promulgated thereunder in reliance on Section 4(2) thereof, relating to offers of securities by an issuer not involving any public offering:


In January 2018, we issued Al & J Media an additional 150,000 shares for media consulting services pursuant to an extension of their September 2017 Consulting Agreement.


In January 2018, we issued Colleen DiClaudio, a board member, 7,813 Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares were issued from our 2016 equity compensation plan.



39





In January 2018, we issued Hardy Thomas, a former board member, 7,195 Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares were issued from our 2016 equity compensation plan.


In January 2018, we issued Marc Savas and Malcolm CasSelle each 3,774 Class A common shares valued at $10,000 as payment for their respect 2017 service on our board of directors. The shares were issued from our 2016 equity compensation plan.


On March 31, 2018, 122,950 shares of Class A common stock were awarded to one employee for sales performance achievement pursuant to our 2016 equity compensation plan.


ITEM 3.

DEFAULTS UPON SENIOR SECURITIES.


None.


ITEM 4.

MINE SAFETY DISCLOSURES.


Not applicable to our company’s operations.


ITEM 5.

OTHER INFORMATION.


On March 20, 2018, as we began to formally review potential strategic options for SRAXMD, we entered into certain retention and bonus agreements with SRAXMD employees, including Erin DeRuggiero, our chief innovations officer. Pursuant to the terms of the agreements with Ms. DeRuggiero, her employment agreement was terminated, and she became a consultant of the Company. The term of the consultancy expires in the second quarter of 2018, or upon the sale of the assets comprising SRAXmd, but may be extended by the parties. The terms of the consultancy are substantially similar to her prior employment agreement except that in the event of a sale of the SRAXmd business unit or substantially all of the assets thereof within 120 days from March 20, 2018, (i) we (or our assignee) have the right and the obligation to purchase all of Ms. DeRuggiero’s outstanding Class A common shares (514,667) at a price of $5.80 per share, or an aggregate of $2,985,069 and (ii) we will pay Ms. DeRuggiero, an amount equal to five percent (5%) of the cash consideration received from the sale of the SRAXmd business. The Company and Ms. DeRuggiero agreed to a customary release from any claims that may have arisen during her employment.


ITEM 6.

EXHIBITS.


 

 

 

 

 

 

Incorporated by Reference

 

 

 

 

Filed/

 

 

 

 

 

 

 

 

Exhibit

 

 

 

Furnished

 

 

 

Exhibit

 

 

 

Filing

No.

 

Description

 

Herewith

 

Form

 

No. 

 

File No.

 

Date

                    

   

 

   

                    

   

                    

   

                    

   

                    

   

                    

3.01(i)

 

Certificate of Incorporation, filed on 8/3/11

 

 

 

S-1

 

3.01(i)

 

333-179151

 

1/24/12

3.02(i)

 

Certificate of Correction to Certificate of Incorporation, filed on 8/31/11

 

 

 

S-1

 

3.01(ii)

 

333-179151

 

1/24/12

3.03(i)

 

Certificate of Amendment to Certificate of Incorporation authorizing 1:5 reverse stock split

 

 

 

8-K

 

3.5

 

000-54996

 

9/19/16

3.04(i)

 

Certificate of Designation of Series 1 Preferred Stock

 

 

 

8-K

 

3.4

 

000-54996

 

8/22/13

3.05(ii)

 

Bylaws of Social Reality, Inc. adopted in August 2011

 

 

 

S-1

 

3.03

 

333-179151

 

1/24/12

4 .01

 

Specimen of Class A Common Stock Certificate

 

 

 

8-A12B

 

4.1

 

001-37916

 

10/12/16

4.02

 

Class A Common Stock Purchase Warrant Issued to Investors in October 2014

 

 

 

8-K

 

4.7

 

000-54996

 

11/4/14

4.03

 

Class A Common Stock Purchase Warrant issued in Steel Media Transaction dated October 30, 2014

 

 

 

8-K

 

4.8

 

000-54996

 

11/4/14

4.04

 

Class A Common Stock Warrant issued in September 2016 Offering

 

 

 

8-K

 

4.6

 

000-54996

 

10/6/16

4.05

 

Class A Common Stock Warrant issued to October 2013 Offering

 

 

 

8-K

 

4.7

 

000-54996

 

10/24/13



40








4.06

 

Class A Common Stock Warrant issued to T.R. Winston & Company issued 8/22/13

 

 

 

10-Q

 

4.5

 

000-54996

 

11/13/13

4.07

 

Class A Common Stock Warrant issued to Investors in January 2014 Offering

 

 

 

8-K

 

4.6

 

000-54966

 

1/27/14

4.08

 

Class A Common Stock Warrant issued to Investors in September 2016

 

 

 

8-K

 

4.6

 

000-54966

 

10/6/16

4.09

 

Class A Common Stock Warrant issued to Investors in January 2017 Offering

 

 

 

8-K

 

4.1

 

001-37916

 

1/4/17

4. 10

 

Class A Common Stock Warrant issued to Investors in January 2017 Offering (2 nd Warrant)

 

 

 

8-K

 

4.2

 

001-37916

 

1/4/17

4.11

 

Class A Common Stock Placement Agent Warrant issued in January 2017 Offering

 

 

 

8-K

 

4.3

 

001-37916

 

1/4/17

4.12

 

Class A Common Stock Placement Agent Warrant issued in October 2016 Offering

 

 

 

10-K

 

4.12

 

001-37916

 

3/31/17

4.13

 

Class A Common Stock Warrant issued in Leapfrog Media Trading Acquisition

 

 

 

10-K

 

4.13

 

001-37916

 

4/2/18

4.14

 

Form of 12.5% Secured Convertible Debenture issued in April 2017 Offering

 

 

 

8-K

 

4.2

 

001-33672

 

4/21/17

4.15

 

Class A Common Stock Warrant issued in April 2017 Offering

 

 

 

8-K

 

4.1

 

001-33672

 

4/21/17

4.16

 

Form of Class A Common Stock Placement Agent Warrant issued in April 2017 Offering

 

 

 

8-K

 

4.3

 

001-33672

 

4/21/17

4.17**

 

2016 Equity Compensation Plan

 

 

 

1/20/17

 

A-1

 

001-37916

 

1/20/17

4.18**

 

2014 Equity Compensation Plan

 

 

 

8-K

 

10.33

 

000-54996

 

11/10/14

4.19

 

2012 Equity Compensation Plan

 

 

 

S-1

 

4.02

 

333-179151

 

1/24/12

4.20

 

Form of Stock Option Agreement for 2012, 2014 and 2016 Equity Compensation Plan

 

 

 

S-1

 

4.03

 

333-179151

 

1/24/12

4.21

 

Form of Restricted Stock Unit Agreement for 2012, 2014 and 2016 Equity Compensation Plan

 

 

 

8-K

 

4.04

 

333-179151

 

1/24/12

4.2 2

 

Form of Restricted Stock Award Agreement for 2012, 2014 and 2016 Equity Compensation Plan

 

 

 

8-K

 

4.05

 

333-179151

 

1/24/12

4.23

 

Form of 12.5% Secured Convertible Debenture issued in October 2017 Offering

 

 

 

8-K

 

4.01

 

001-37916

 

10/27/17

4.24

 

Class A Common Stock Warrant Issued to Investors and Placement Agents in October 2017 Offering

 

 

 

8-K

 

4.02

 

001-37916

 

10/27/17

10.0 1

 

Purchase Agreement among Richard Steel, Steel Media, and Social Reality, dated 10/30/14

 

 

 

8-K

 

2.1

 

000-54996

 

11/4/14

10.02

 

Asset Purchase Agreement with LeapFrog Media Trading dated 4/20/17

 

 

 

10-K

 

10.02

 

001-37916

 

4/2/18

10.03

 

Amendment to Asset Purchase Agreement with Leapfrog Media Trading dated 8/17/17

 

 

 

10-K

 

10.03

 

001-37916

 

4/2/18



41








10.04

 

Transition Services Agreement in Leapfrog Media Trading Transaction

 

 

 

10-K

 

10.04

 

001-37916

 

4/2/18

10.05

 

Sample Leakout Agreement in Leapfrog Media Trading Transaction

 

 

 

10-K

 

10.05

 

001-37916

 

4/2/18

10. 06

 

Form of Securities Purchase Agreement for April 2017 Offering

 

 

 

8-K

 

10.1

 

001-37916

 

4/21/17

10.0 7

 

Form of Security Agreement for April 2017 Offering

 

 

 

8-K

 

10.2

 

001-37916

 

4/21/17

10. 08

 

Form of Registration Rights Agreement for April 2017 Offering

 

 

 

8-K

 

10.3

 

001-37916

 

4/21/17

10.09

 

Form of Securities Purchase Agreement for October 2017 Offering

 

 

 

8-K

 

10.01

 

001-37916

 

10/27/17

10.10

 

Form of Registration Rights Agreement for October 2017 Offering

 

 

 

8-K

 

10.02

 

001-37916

 

10/27/17

10.11**

 

Employment Agreement with Christopher Miglino dated 1/1/12

 

 

 

S-1

 

10.01

 

333-179151

 

1/24/12

10.12**

 

Employment Agreement with Erin DeRuggiero dated 10/19/15

 

 

 

10-K

 

10.3

 

000-54996

 

2/26/16

10.13**

 

Employment Agreement with Joseph P. Hannan dated 10/17/16

 

 

 

10-Q

 

10.48

 

001-37916

 

11/14/16

10.14**

 

Employment Agreement with Richard Steel dated 10/30/14

 

 

 

8-K

 

10.27

 

000-54996

 

11/4/14

10.15**

 

Employment Agreement with Chad Holsinger dated 10/30/14

 

 

 

8-K

 

10.28

 

000-54996

 

11/4/14

10.16

 

Employment Agreement with Adam Bigelow dated 10/30/14

 

 

 

8-K

 

10.29

 

000-54996

 

11/4/14

10. 17**

 

Separation Agreement and Release with Richard Steel dated 1/25/17

 

 

 

8-K

 

10.1

 

333-215791

 

1/27/17

10.18**

 

Employment Agreement with Dustin Suchter dated 12/19/14

 

 

 

8-K

 

10.36

 

000-54996

 

12/22/14

10.16**

 

Form of Proprietary Information, Inventions and Confidentiality Agreement

 

 

 

S-1

 

10.03

 

333-179151

 

1/25/12

10.17**

 

Form of Indemnification Agreement with Officers and Directors

 

 

 

S-1

 

10.04

 

333-179151

 

1/25/12

10.18

 

Indemnification Agreement with Richard Steel dated 10/30/14

 

 

 

8-K

 

10.30

 

333-215791

 

11/4/14

10.19

 

Sublease for principal executive offices dated 8/12/12 with TrueCar, Inc.

 

 

 

S-1

 

10.16

 

333-193611

 

1/28/14

10.20

 

Services Agreement with Servicios y Asesorias Planic, S.A. de cv dated 1/25/13

 

 

 

10-K

 

10.9

 

000-54996

 

3/31/15

10.21

 

Sublease Agreement with Amarcore, LLC dated 1/1/15

 

 

 

S-1

 

10.17

 

333-206791

 

9/4/15

10.22

 

Advisory Agreement with Kathy Ireland Worldwide, LLC dated 11/14/16

 

 

 

10-Q

 

10.49

 

001-37916

 

11/14/16

10.23

 

Financing and Security Agreement with FastPay Partners, LLC

 

 

 

8-K

 

10.41

 

000-54996

 

9/23/16

10.24

 

Share Acquisition and Exchange Agreement with Five Delta, Inc.

 

 

 

8-K

 

10.34

 

000-54996

 

12/22/14

10.25

 

Secured Subordinated Promissory Note to Richard Steel dated 10/30/14

 

 

 

8-K

 

10.18

 

000-54996

 

11/4/14

10.27

 

Subordination Agreement with Richard Steel and Victory Park Management, LLC dated 10/30/14

 

 

 

8-K

 

10.22

 

000-54996

 

11/4/14

10.28

 

Securities Purchase Agreement for January 2017 Offering

 

 

 

8-K

 

10.1

 

001-37916

 

1/4/17



42








10.29

 

Placement Agent Agreement for January 2017 Offering with Chardan Capital Markets

 

 

 

8-K

 

10.2

 

001-37916

 

1/4/17

10.30

 

Financing Agreement with certain Lenders and Victory Park Management, LLC

 

 

 

8-K

 

10.23

 

000-54996

 

11/4/14

10.31

 

First Amendment to Financing Agreement dated 5/14/15

 

 

 

10-Q

 

10.38

 

000-54996

 

5/15/15

10.32

 

Pledge and Security Agreement with Steel Media and Victory Park Management, LLC dated 10/30/14

 

 

 

8-K

 

10.25

 

000-54996

 

11/4/14

10.33

 

Registration Rights Agreement dated 10/30/14

 

 

 

8-K

 

10.26

 

000-54996

 

11/4/14

10.34

 

Forbearance Agreement with Steel Media, Five Delta, Inc, Lenders and Victory Park Management, LLC dated 8/22/16

 

 

 

8-K

 

10.46

 

000-54996

 

8/24/16

10.36

 

Letter Agreement dated 1/5/17

 

 

 

10-K

 

10.35

 

001-37916

 

3/31/17

10.37

 

Insider Trading Policy adopted as of 2/23/16

 

 

 

10-K

 

10.36

 

001-37916

 

3/31/17

10.38**

 

Agreements with Erin DeRuggiero dated March 20, 2018

 

*

 

 

 

 

 

 

 

 

18.01

 

Preference Letter regarding Change in Accounting Principle

 

 

 

10-Q

 

18.1

 

001-37916

 

11/14/16

31.1 / 31.2

 

Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

*

 

 

 

 

 

 

 

 

32.1 / 32.2

 

Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. § 1350

 

*

 

 

 

 

 

 

 

 

101.INS

 

XBRL Instance Document

 

*

 

 

 

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema

 

*

 

 

 

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase

 

*

 

 

 

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase

 

*

 

 

 

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase

 

*

 

 

 

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase

 

*

 

 

 

 

 

 

 

 

———————

**

 

Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.




43





SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 

SOCIAL REALITY, INC.

 

 

 

 

 

 

May 15, 2018

By:

/s/ Christopher Miglino

 

 

Christopher Miglino, Chief Executive Officer, principal executive officer


May 15, 2018

By:

/s/ Joseph P. Hannan

 

 

Joseph P. Hannan, Chief Financial Officer, principal financial and accounting officer







44


 


EXHIBIT 10.38


Bonus and Stay Agreement


This Confidential Settlement Agreement and General Release (the “Agreement” or “Settlement Agreement”) is made and entered into as of March 20, 2018 (the “Effective Date”) by and between Erin DeRuggiero (“DeRuggiero”), on the one hand, and Social Reality, Inc. (“SRAX” or the “Company”), on the other hand.


RECITALS


WHEREAS, DeRuggiero has been employed by SRAX as Co-Founder, Chief Innovations Officer pursuant to a certain initial Employment Agreement dated January 1, 2012, which was subsequently terminated and superseded by a revised Employment Agreement dated October 19, 2015 (the “Employment Agreement”);


WHEREAS, the Employment Agreement provides, among other things, for payment by SRAX to DeRuggiero of certain “Commission(s),” as defined therein;


WHEREAS, also in connection with her employment, DeRuggiero was granted, received and is the current owner of record of 514,667 shares of SRAX restricted stock (the “Stock”);


WHEREAS, SRAX is actively entertaining offers from potential buyers to sell its SRAXmd division, and seeks to maintain a relationship with DeRuggiero during this period to help facilitate a sale; and


NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, and intending to be and being legally bound hereby, the Parties agree as follows:

AGREEMENT


1.

The Employment Agreement is hereby terminated and of no further force or effect, with the exception of: (i) certain remedies therein are subject to reinstatement pursuant to Paragraph 3 below; and (ii) the terms of the Confidentiality Agreement described in Paragraph 7




 


of the Employment Agreement and Exhibit A of the same shall survive and remain in effect pursuant to said paragraph’s terms.  DeRuggiero shall cooperate in good faith with SRAX to turn over or otherwise provide full access to all of DeRuggiero’s work product and other SRAX trade secrets which the Parties acknowledge and agree is and shall remain the sole and exclusive property of SRAX.  DeRuggiero’s execution of this Agreement shall be deemed to be her voluntary resignation of her employment with SRAX.


2.

In place of the Employment Agreement, the Parties agree to execute a consulting agreement in the form annexed hereto as Exhibit 1 hereto (the “Consulting Agreement”) the term of which shall continue from the Effective Date up to and including May 31, 2018 (the “Consulting Term”).  The Consulting Agreement shall be executed by all Parties and become effective and enforceable concurrently with this Agreement.  The Parties may agree in writing to extend the Consulting Agreement for any period of time beyond the Consulting Term.


3.

During the Consulting Term, in the event that SRAX reaches a fully-executed written letter of intent or written term sheet with a buyer that contains terms that result in a sale of the SRAXmd business unit or substantially all of the assets thereof, and the sale closes within one-hundred and twenty (120) calendar days of the Effective Date of this Agreement (a “Sale”), the Parties shall become obligated to perform as follows (with SRAX agreeing to act in good faith with DeRuggiero in establishing the date of the closing of the Sale or timing for execution of a letter of intent, term sheet or similar document related thereto, and with the parties agreeing in good faith to negotiate with each other concerning reasonable extensions to these dates to accommodate any sale that the parties believe is reasonably likely to occur):


(i)

SRAX, on behalf of itself and its representatives, officers, directors, trustees, employees, agents, and any other persons acting for or in concert with any of them, hereby releases DeRuggiero (including her heirs, executors, administrators, agents, assigns and dependents) (the “DeRuggiero Releasees”) from any and all claims, in law or




 


equity, which SRAX ever had or now has regarding any matter arising on or before the Effective Date, whether or not SRAX suspects or knows such claims exist.  The Parties intend SRAX’s release to be general and comprehensive in nature and to release all claims against the DeRuggiero Releasees to the maximum extent permitted by law;  


(ii)

SRAX (or its assignee) shall purchase from DeRuggiero, and DeRuggiero shall sell to SRAX (or its assignee), all 514,667 shares of her restricted stock at a price of $5.80 per share for a total amount of two million nine-hundred eighty-five thousand sixty-eight dollars and sixty cents ($2,985,068.60), which amount shall be paid within ten (10) business days of the closing of a Sale and SRAX’s receipt of cash consideration at the closing of such Sale.  DeRuggiero shall present all stock certificates and any other necessary documentation required to facilitate the sale.  The Parties each acknowledge that they have valued and considered goodwill of the business as a component of the aforementioned sale price, as contemplated in section 16601 of the California Business & Professions Code;


(iii)

SRAX shall pay DeRuggiero an additional amount equivalent to five percent (5%) of the cash consideration paid by buyer as determined on the day SRAX actually receives said cash consideration, net of customary transaction fees and expenses (e.g., legal fees and banking fees expended in connection with the transaction), such amounts not to exceed $3,000,000.   The amount(s) due hereunder shall be paid within ten (10) business days of SRAX’s receipt of such cash consideration;


(iv)

SRAX shall pay DeRuggiero any unpaid 2018 Commission amounts for months that have been closed by SRAX from an accounting standpoint, as defined in the Consulting Agreement, and regardless of whether payments have been received by the applicable customer and thus fully earned by DeRuggiero as of the closing date of a Sale.  




 


This amount shall be paid within ten (10) business days of the closing of a Sale and SRAX’s receipt of the cash consideration referred to in Paragraph 4(ii) above;


(v)

DeRuggiero agrees, for a period of one (1) year following closing of a Sale, not to obtain employment or perform services in a role involving media sales relating to healthcare professionals or the healthcare industry, and further agrees not to solicit individuals known to be employed by the buyer and/or the purchased SRAXmd business unit or otherwise solicit any of SRAX’s customers or vendors, provided, however, that such non-compete and non-solicit obligations shall only apply in the event that the before-tax amount received by DeRuggiero pursuant to 5(iii) above shall exceed three million dollars ($3,000,000); and


(vi)

DeRuggiero shall negotiate in good faith with the buyer of the SRAXmd business unit in connection with remaining as a consultant or employee for a period of time to be mutually agreed upon (which the Parties anticipate to be not less than one year).


4.

In the event that SRAX has failed to reach a fully-executed written letter of intent or written term sheet with a buyer that contains terms that would result in a Sale at the conclusion of the Consulting Term, or a closing of a Sale has not occurred within one hundred twenty (120) calendar days of the Effective Date, SRAX agrees to take such steps as necessary to facilitate the lawful removal of the “restricted” legend from the Stock and deliver the Stock to DeRuggiero within ten (10) business days of the applicable non-occurrence.  DeRuggiero acknowledges and agrees that she (and her ownership of the Stock) will still be subject to applicable state and federal securities laws and agrees to abide thereby (including, without limitation, not acting on any material non-public information related to SRAX or its stock).


5.

DeRuggiero represents that she has not filed any claim, action, proceeding or submission seeking damages or equitable relief for herself with a court, government agency or




 


regulatory body which arises out of or relates in any manner to her employment by SRAX, other than as may be permitted under Paragraph 10, below.


6.

In consideration of the covenants undertaken herein by SRAX, and except for those obligations created by or arising out of the Agreement, DeRuggiero, on her own behalf and on behalf of her descendants, dependents, heirs, executors, administrators, assigns and successors, does hereby covenant not to sue and acknowledges full and complete satisfaction of and hereby releases, absolves and discharges SRAX and each of their predecessors, successors and assigns, parent, subsidiaries, divisions, and sister and affiliated corporations, past and present, as well as its and their respective trustees, directors, officers, shareholders, agents, attorneys, insurers, employees, independent contractors, and consultants, past and present, and each of them, including but not limited to, Chris Miglino, JP Hannan, Collen DiClaudio, Robert Jordan, Marc Savas, Malcolm CasSelle, and Kristoffer Nelson (hereinafter collectively referred to as the “SRAX RELEASEES”), with respect to and from any and all claims, demands, liens, agreements, contracts, covenants, actions, suits, causes of action, wages, obligations, debts, expenses, attorneys’ fees, damages, judgments, orders, and liabilities of whatever kind or nature in law, equity, or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not concealed or hidden, that DeRuggiero now owns or holds or has at any time heretofore owned or held as against said SRAX RELEASEES, including specifically but not exclusively and without limiting the generality of the foregoing any and all claims, demands, agreements, obligations and causes of action, known or unknown, suspected or unsuspected by DeRuggiero:


(i)

Alleged, set forth, or arising out of or in any way connected with any transactions, occurrences, acts or omissions any claims that DeRuggiero may have related to her employment with SRAX, whether or not such claims arise under federal, state, or




 


local constitution, law, ordinance, regulation, executive order, tort, contract (express, quasi or implied), public policy, common law, or any other source;


(ii)

Arising out of or in any way connected with any transactions, occurrences, acts or omissions set forth, or facts alleged, in any and all charges, complaints, claims or pleadings filed by DeRuggiero against any of the SRAX RELEASEES prior to the date hereof with any city, county, state or federal agency, commission office or tribunal whatsoever;


(iii)

Arising out of or in any way connected with any transactions, occurrences, acts or omissions occurring prior to the date hereof, including specifically without limiting the generality of the foregoing, claims for retaliation or whistle blowing, negligent hiring, retention, or supervision, serious and willful misconduct; misclassification; discrimination in violation of Labor Code section 132a; wrongful discharge, breach of contract, breach of the covenant of good faith and fair dealing, fraud, violation of public policy, defamation, intentional or negligent infliction of emotional distress, unjust enrichment, all other claims for unlawful employment practices, and all claims for severance pay, bonus, sick leave, holiday pay, vacation pay, life insurance, health and medical insurance, or any other fringe benefit; or


(iv)

Arising under any statute applicable to DeRuggiero’s employment, including specifically without limiting the generality of the foregoing, any claims under Title VII of the Civil Rights Act of 1964, the California Fair Employment and Housing Act, the Equal Pay Act of 1963, the California Labor Code, the California Business and Professions Code, the Age Discrimination in Employment Act of 1967, the Older Worker’s Benefit Protection Act of 1990, the Family and Medical Leave Act, the California Family Rights Act, the Americans with Disabilities Act, and all other state or federal statutes potentially applicable to DeRuggiero’s employment with SRAX.




 


Nothwithstanding the foregoing, the release provided by DeRuggiero hereunder shall not include or apply to any claims relating to SRAX’s obligations under this Settlement Agreement, the Consulting Agreement, any indemnification right from SRAX that DeRuggiero may have, or any rights that DeRuggiero may have under any SRAX benefit/retirement plan.


7.

DeRuggiero expressly acknowledges and agrees that, by entering into this Agreement, she is waiving any and all rights or claims that she may have arising under the Age Discrimination in Employment Act of 1967, as amended, which have arisen on or before the date of execution of this Agreement.  DeRuggiero further expressly acknowledges and agrees that:


(i)

In return for this Agreement, she will receive consideration beyond that which she was already entitled to receive before entering into this Agreement;


(ii)

She is hereby advised in writing by this Agreement to consult with her attorney before signing this Agreement;


(iii)

She was given a copy of this Agreement on March 20, 2018, and informed that she had twenty-one (21) days within which to consider the Agreement; and


(iv)

She was informed that she has seven (7) days following the date of execution of this Agreement in which to revoke the Agreement.


8.

Revocation Period.   DeRuggiero may revoke this Agreement in its entirety during the seven (7) calendar days following execution of the Agreement by DeRuggiero.  Any revocation of the Agreement must be in writing and hand delivered during the revocation period to SRAX’s attorney, Michael J. Studenka, at Newmeyer & Dillion LLP, 895 Dove Street, 5 th Floor, Newport Beach, California.  This Agreement will become effective and enforceable on the eighth (8 th ) day following execution by DeRuggiero, unless it is revoked during the seven-day revocation period.


9.

California Civil Code Section 1542 Waiver .  It is a further condition of the consideration hereof and is the intention of the Parties in executing this instrument that the same




 


shall be effective as a bar as to each and every claim, demand, and cause of action hereinabove specified and, in furtherance of this intention, the Parties hereby expressly waive any and all rights or benefits conferred by the provisions of SECTION 1542 OF THE CALIFORNIA CIVIL CODE and expressly consents that this Agreement shall be given full force and effect according to each and all of its express terms and conditions, including those relating to unknown and unsuspected claims, demands and causes of actions, if any, as well as those relating to any other claims, demands and causes of actions hereinabove specified.  SECTION 1542 provides:


“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”


The Parties acknowledge that they may hereafter discover claims or facts in addition to or different from those that they now know or believe to exist with respect to the subject matter of this Agreement and that, if known or suspected at the time of executing this Agreement, may have materially affected this settlement.  Nevertheless, the Parties hereby waive any right, claim or cause of action that might arise as a result of such different or additional claims or facts.  Nothing in this paragraph is intended to limit the Parties’ right to enforce the terms of this Agreement or the Consulting Agreement.


10.

The release of claims do not extend to the Parties’ contractual right to enforce the terms of this Agreement or to any claims that may not be lawfully released.  In addition, the release of claims in Paragraph 8 shall be deemed void and of no effect, in its entirety, in the event SRAX breaches its obligations under Paragraphs 1, 4(i), 4(ii), 4(iii) and 4(iv) and 5 herein.  Additionally, the release of claims in Paragraph 4(i) shall be deemed void and of no effect, in its entirety, in the event DeRuggiero breaches her obligations under surviving provisions of the




 


Employment Agreement, Paragraphs 3, 4(v), 4(vi), 14 and/or 15 herein, or the Consulting Agreement.


11.

Nothing in this Agreement prevents DeRuggiero from filing a charge with, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission or a state fair employment practices agency, except that by executing (and not revoking) this Agreement, DeRuggiero acknowledges that she is giving up her right to seek, and hereby waives, individual damages in connection with any legal proceedings with respect to any claim that has been lawfully released.  Nothing in this Agreement shall, or shall be construed to, limit DeRuggiero’s right, if any, under Section 7 of the National Labor Relations Act and/or other applicable laws to discuss the terms and conditions of her employment or to engage in protected concerted activity as defined by law.  


12.

No Admissions .  Neither this Agreement nor anything in this Agreement shall be construed to be or shall be admissible in any proceeding, whether or not the Parties are involved, as evidence of liability or wrongdoing by either party or by any releasee.  This Agreement may be introduced, however, in any proceeding to enforce the Agreement.  Such introduction shall be pursuant to an order protecting its confidentiality.


13.

Non-Disparagement.  DeRuggiero will refrain from making any representation or statement, whether written or oral, to any person or entity, including but not limited to customers of SRAX, which reflects any opinion, judgment, observation or representation which is intended to disparage or otherwise reflect negatively on SRAX, and/or its officers, directors, or employees including.  This provision shall not be interpreted as preventing DeRuggiero from responding truthfully to requests for information in a subpoena or other legal or administrative process.  


14.

Confidentiality .  The Parties agree that the existence and the terms and conditions of this Agreement shall remain confidential as between them and, unless required by law, neither will disclose them to any other person, except to their respective legal and financial advisors,




 


who shall first be advised of this confidentiality provision and shall agree to be bound by it.  Without limiting the generality of the foregoing, (a) none of the Parties will respond to or in any way participate in or contribute to any public discussion, notice, or other publicity concerning or in any way relating to existence or the terms and conditions of this Agreement; (b) DeRuggierro specifically agrees that she will not disclose information regarding this Agreement to any current or former employee or consultant of SRAX; (c) SRAX shall be entitled to inform its employees of the transition  of DeRuggiero’s employment with SRAX before DeRuggiero engages in any communications with any of SRAX’s employees relating thereto; (d) after SRAX has informed its employees of the termination of DeRuggiero’s employment with SRAX, DeRuggiero may only confirm to any SRAX employee DeRuggiero’s last date of employment with SRAX and that she is a consultant for SRAX during the Consulting Term (as that term is defined in the Consulting Agreement); and (e) DeRuggiero acknowledges that SRAX is a corporation that employs many individuals and that the use by executive management of SRAX of their respective best efforts to comply with the terms of Paragraph 15 shall constitute SRAX’S full compliance herewith.  This Agreement may be introduced in any proceeding to enforce the Agreement.  Such introduction shall be pursuant to a court order protecting its confidentiality.  DeRuggiero  and SRAX hereby agree that disclosure in violation of the foregoing shall constitute and be treated as a material breach of this Agreement.   


15.

Inquiries by Subsequent Prospective Employers.   DeRuggiero will direct any request for verification of her employment to Chris Miglino, CEO of SRAX.  If Mr. Miglino receives any inquiry regarding DeRuggiero from a subsequent prospective employer, he will confirm her dates of employment and job titles.  Mr. Miglino will release salary information regarding DeRuggiero only with her express written authorization or when required by law.  No other information will be provided, unless required by law.




 


16.

This Agreement and the Consulting Agreement constitute the entire agreement between the Parties and supersede and replace all prior negotiations and agreements proposed or otherwise, whether written or oral, concerning the subject matter thereof.  This Agreement cannot be altered except in a writing signed by the Parties.  The Parties acknowledge that each party has cooperated in the drafting and preparation of this Agreement, that they entered into this Agreement voluntarily, that they fully understand all of its provisions, and that no representations were made to induce execution of this Agreement which are not expressly contained herein.


17.

The Parties agree that this Agreement shall be governed and construed (both as to validity and performance) and enforced in accordance with the internal laws of the State of California, without regard to principles of conflicts of law or where the Parties are located at the time a dispute arises.  Any unresolved controversy or claim arising out of or relating to this Agreement shall be submitted to arbitration pursuant to Exhibit B to the Consulting Agreement.


18.

This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument.  Facsimile or electronically transmitted signatures shall be treated as original signatures for all purposes.





 



IN WITNESS WHEREOF, the Parties have executed this Agreement on the dates indicated below.

SOCIAL REALITY, INC.:

____________________________

By: _______________________________

Erin DeRuggiero

Name:

Title:

____________________________

__________________________________

Date

Date




 



ACKNOWLEDGEMENT

I, ERIN DERUGGERIO, hereby acknowledge that I was given twenty-one (21) days to consider the foregoing Agreement and voluntarily chose to sign the on the date indicated above.  I was provided this agreement on May __, 2018.  

I declare under penalty of perjury under the laws of the State of California that the foregoing is true and correct.

EXECUTED this ____ day of ____________, 2018, at COUNTY: ________, STATE: ________________.


___________________________________
ERIN DERUGGERIO




 




EXHBIT 1 – CONSULTING AGREEMENT

This CONSULTING AGREEMENT (“Consulting Agreement”), dated as of March 21, 2018, is hereby entered into by and between Social Reality, Inc. (“SRAX” or the “Company”), a Delaware corporation, and Erin DeRuggiero (“Consultant”), an individual residing at 4502 Beard Ave South, Minneapolis, MN 55410.

RECITALS

WHEREAS , the Company and Consultant are parties to that certain Employment Agreement dated as of October 19, 2015 (the “Employment Agreement”);

WHEREAS , the Company and Consultant desire to terminate the Employment Agreement and enter into a consulting arrangement upon the terms and conditions set forth herein, pursuant to which Consultant will be retained by the Company as an outside consultant; and

WHEREAS , the Company and Consultant are parties to a certain Confidential Settlement Agreement and General Release (the “Settlement Agreement”), which provides for certain additional obligations on the part of Consultant and the Company to each other;

NOW, THEREFORE , the Company and Consultant hereby agree as follows:

1.

Term .  The term of this Consulting Agreement shall commence as of March 21, 2018, and shall expire at 6:00 p.m. EST on May 31, 2018 (the “Term”).

2.

Duties .  The Consultant shall have the title of Co-Founder, Special Projects, or similar title.  The Consultant’s duties shall include, among other things, (a) assisting the Company with efforts to explore a potential sale of the SRAXmd business unit (“SRAXmd”), including, among other things, interfacing with potential purchasers of SRAXmd and facilitating information about SRAXmd to potential purchasers, and (b) continuing her regular sales, marketing and other duties that she has been performing under the terms of the Employment Agreement.  The duties and responsibilities of Consultant may be adjusted by the Company in its reasonable discretion including, without limitation, revising to whom she reports as her superior within the Company.

3.

Compensation . For all services rendered by Consultant in any capacity required hereunder during the Term, Consultant shall be compensated as follows:

(a)

Consulting Fee .  The Company shall pay Consultant a fixed consulting fee (“Fee”) at a rate of $90,000 per annum, equating to $22,500 for the Term.  The Fee shall be paid bi-weekly.  This Fee shall be reported to state and federal taxing authorities using Form 1099.




 


(b)

Commissions .  In addition to the Fee, the Company shall pay Consultant a commission (the “Commission”) at the rate of fifteen percent (15%) of the Net profit of SRAXmd for any media buys that have been contracted from January 1, 2018 through the end of the Term based on 2018 insertion orders.  “Net” shall be defined as the revenue for SRAXmd, less any and all expenses associated to SRAXmd as determined by the Company in its absolute discretion.  The Commission shall be paid on a monthly basis upon receipt of payment from the applicable customer, but shall be adjusted on a quarterly basis should SRAXmd experience a Net loss in any given period.  In the event SRAXmd experiences a Net loss, the amount of any such loss shall be deducted from the calculation of Net in future period(s) prior to the calculation of any Commission.  Commissions for each period shall be paid upon receipt of revenue from customers and for months that have been closed from an accounting standpoint.  Consultant’s agreement to the foregoing is without prejudice to rights she may have under the Settlement Agreement, if any, with respect to contesting the Company’s calculations of Net revenue.  If Consultant receives commissions pursuant to Paragraph 4(iv) of the Settlement Agreement, then she shall not be entitled to further Commissions under this Section 3(b).  For the avoidance of doubt, Consultant shall not be entitled to duplicate commission payments pursuant to Paragraph 4(iv) of the Settlement Agreement and this Section 3(b).

(c)

Determination of Amounts of Commission .  The amounts of any Commission, if any, that Consultant is entitled to receive shall be determined by the Company based upon its consolidated financial statements prepared in accordance with U.S. generally-accepted accounting principles, consistently applied.

4.

Travel and Business Expenses .  Consultant may be required by the Company to travel in connection with performing her duties hereunder.  The Company agrees to provide Consultant with at least seventy-two (72) hours’ advance written notice of any such required travel, unless exigent circumstances require a shorter notice period.  The Company shall pay Consultant for all necessary expenses reasonably incurred by Consultant in connection with the performance of the Executive’s duties and obligations under this Agreement, subject to Consultant’s presentation of appropriate vouchers in accordance with such expense account policies and approval procedures as the Company may from time to time reasonably establish for its employees (including but not limited to prior approval of extraordinary expenses).  With the exception of travel expenses, Consultant agrees to obtain prior written approval from the Company before incurring any single out-of-pocket expense in connection with the Consultant’s performance of her duties and obligations under this Consulting Agreement in excess of $2,500.00 (or such higher limit as permitted by the Employer’s Chief Executive Officer).  

5.

Termination .  This Consulting Agreement shall terminate at the earlier of (i) the end of the Term; or (ii) upon closing of a sale of SRAXmd.  The termination date specified in any notice of termination shall be referred to herein as the “Termination Date.”  

(a)

Accrued Obligations .  In the event this Consulting Agreement is terminated for any reason, Consultant shall be entitled to no compensation or other benefits of any kind whatsoever, other than: (i) payment of the Consultant’s unpaid Fee through the Termination Date, payable upon the next regular bi-weekly pay date following the Termination Date (or such earlier date as may be required by applicable law); (ii) payment of any earned but unpaid Commission under section 3(b), payable in accordance therewith; (iii) expenses reimbursable under Section 4 incurred on or prior to the Termination Date, but not yet reimbursed, which reimbursable (but not yet reimbursed) expenses, if any, shall be paid on the Company’s next regular payroll date that occurs after the Termination Date (or as soon thereafter




 


as administratively practicable; and (iv) any unpaid compensation or consideration due under the Settlement Agreement (the foregoing payments and benefits collectively referred to herein as “Accrued Obligations”).

(b)

Death of Consultant .  In the event of the death of the Consultant during the term of this Consulting Agreement, the Accrued Obligations shall be payable to Consultant’s estate or designated beneficiary(ies).

(c)

No Mitigation .  In no event shall Consultant be obligated to seek other sources of income or take any other action by way of mitigation of the amounts payable to the Consultant under any of the provisions of this Consulting Agreement, nor shall the amount of any payment hereunder be reduced by any compensation earned by Consultant as a result of subsequent sources of income.

6.

Nature of Relationship .  For purposes of the Federal Insurance Contributions (“FICA”), the Federal Unemployment Contributions Act, the collection of State and Federal Income Tax at source of wages, and each State’s Workers Compensation Act, the relationship between the Company and Consultant is that of a company and an independent contractor.  As such:

(a)

The Company will not withhold any monies for any Federal, State, or local taxing authorities from any Fee or Commission earned by Consultant pursuant to this Consulting Agreement;

(b)

The Company agrees that Consultant may perform services for other companies and entities during the Term, subject to certain limited and contingent non-competition obligations set forth in Paragraph 5(v) of the Settlement Agreement.

7.

Assignments of Developments; Works for Hire .  If at any time or times during the Term, Consultant shall (either alone or with others) make, conceive, discover or reduce to practice any invention, modification, discovery, design, development, improvement, process, software program, work-of-authorship, documentation, formula, data, technique, know-how, secret or intellectual property right whatsoever or any interest therein (whether or not patentable or registrable under copyright or similar statutes or subject to analogous protection) (herein called “ Developments ”) that results from tasks assigned to Consultant by the Company, such Developments and the benefits thereof shall immediately become and/or be considered as the sole and absolute property of the Company and its assigns as a work for hire, and the Consultant shall promptly disclose to the Company (or any persons designated by it) each such Development and hereby assigns any rights Consultant may have or acquire in the Developments and benefits and/or rights resulting therefrom to the Company and its assigns without further compensation and shall communicate, without cost or delay, and without publishing the same, all available information relating thereto (with all necessary documentation, plans and models) to the Company. Upon disclosure of each Development to the Company, Consultant will, during the Term and at any time thereafter, at the request and cost of the Company, sign, execute, make and do all such deeds, documents, acts and things as the Company and its duly authorized agents may reasonably require:

(a)

to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) letters patent, copyrights, trademarks, service marks or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same; and




 


(b)

to defend any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for revocation of such letters patent, copyrights, trademarks, service marks or other analogous protection

In the event the Company is unable, after reasonable effort, to secure the Consultant’s signature on any letters patent, copyrights, trademarks, service marks or other analogous protection relating to a Development, whether because of the Consultant’s physical or mental incapacity or for any other reason whatsoever, the Consultant hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Consultant’s agent and attorney-in-fact, to act for and on her behalf and stead to execute and file any such application or applications and to do all other lawfully permitted acts to further the prosecution and issuance of any such letters patent, copyrights, trademarks, service marks and other analogous protection thereon with the same legal force and effect as if executed by the Consultant.


8.

Confidentiality .  Consultant shall execute, and abide by the terms of, the confidentiality/non-disclosure agreement in the form annexed hereto as Exhibit A (the “Confidentiality Agreement”), the terms of which are incorporated herein.

9.

Notices .  All notices, requests, demands and other communications required or permitted hereunder shall be given in writing, and shall be deemed effective upon (a) personal delivery, if delivered by hand, (b) three (3) days after the date of deposit in the mails, postage prepaid, if mailed by certified or registered United States mail, or (c) the next business day, if sent by a prepaid overnight courier service, and in each case addressed as follows (unless otherwise previously specified in writing):

(a)

To the Company:

Social Reality, Inc.

456 Eaton Street

Los Angeles, C.A. 90013

Attention: Christopher Miglino, Chief Executive Officer


(b)

To Consultant:

Harris, St. Laurent & Chaudhry LLP

40 Wall Street, 53 rd Floor

New York, N.Y. 10005

Attention: Jonathan Harris, Esq. and Yonaton Aronoff, Esq.


10.

Binding Agreement; No Assignment .  This Consulting Agreement shall be binding upon, and shall inure to the benefit of, the Consultant, the Company and their respective permitted successors, assigns, heirs, beneficiaries and representatives.  This Consulting Agreement is personal to the Consultant and may not be assigned by the Consultant without the prior written consent of the Company’s Board, as evidenced by a resolution of the Board.  Any attempted assignment in violation of this Section 9 shall be null and void.

11.

Governing Law; Consent to Jurisdiction; Arbitration .  This Agreement, and all matters arising directly or indirectly from this Consulting Agreement, shall be governed by, and construed and interpreted in accordance with, the laws of the State of California, without giving effect to the choice of law provisions thereof.  Any dispute, claim or controversy arising




 


out of or relating to this Agreement or the breach, termination, enforcement, interpretation or validity thereof, including the determination of the scope or applicability of this Agreement to arbitrate, shall be determined by arbitration in Orange County, California before one arbitrator. The arbitration shall be administered by JAMS pursuant to its Comprehensive Arbitration Rules and Procedures. Judgment on the Award may be entered in any court having jurisdiction. This clause shall not preclude parties from seeking provisional remedies in aid of arbitration from a court of appropriate jurisdiction.  In the event either party institutes arbitration under this Agreement, the party prevailing in any such arbitration shall be entitled, in addition to all other relief, to reasonable attorneys' fees relating to such arbitration.  The non-prevailing party shall be responsible for all costs of the arbitration, including but not limited to, the arbitration fees, court reporter fees, etc..

12.

Entire Agreement .  This Consulting Agreement, including all Exhibits hereto, along with the Settlement Agreement, shall constitute the entire agreement between the parties with respect to the matters covered hereby and supersedes all previous written, oral or implied understandings between them with respect to such matters, including without limitation, any “employment” or similar agreements (whether written, oral or implied) between the Company and Consultant (including the Employment Agreement).  Notwithstanding anything in this Consulting Agreement to the contrary, Consultant shall have no liability to the Company or any other person or entity (and all such liability is hereby irrevocably waived, discharged and released, which such waiver, discharge and release are a material inducement to Consultant for entering into this Agreement) whatsoever of any kind for any consequential, special, punitive or other similar damages, whether foreseeable, known to Consultant, or even if Consultant was advised thereof.

13.

Amendments .  This Consulting Agreement may only be amended or otherwise modified by a writing executed by each of the parties hereto.

14.

Survivorship .  The provisions of Sections 5 through 14, as well as Exhibits A and B hereto, shall survive the termination of this Consulting Agreement.

15.

Counterparts .  This Consulting Agreement may be executed in any number of counterparts or facsimile copies, each of which when executed shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.

IN WHITNESS WHEREOF, the Company has caused this Agreement to be executed and delivered by its dully authorized officer and Consultant has signed this Consulting Agreement, all as of the first date written above.

SOCIAL REALITY, INC.


By: _____________________________

Christopher Miglino

Chief Executive Officer


CONSULTANT :


By: _____________________________

Erin DeRuggiero




EXHIBIT 31.1


Rule 13a-14(a)/15d-14(a) Certification


I, Christopher Miglino, certify that:


1.

I have reviewed this report on Form 10-Q for the period ended March 31, 2018 of Social Reality, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Dated:  May 15, 2018

 

/s/ Christopher Miglino

Christopher Miglino, Chief Executive Officer, principal executive officer




EXHIBIT 31.2


Rule 13a-14(a)/15d-14(a) Certification


I, Joseph P. Hannan, certify that:


1.

I have reviewed this report on Form 10-Q for the period ended March 31, 2018 of Social Reality, Inc.;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

 

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Dated: May 15, 2018

 

/s/ Joseph P. Hannan

Joseph P. Hannan, Chief Financial Officer, principal financial and accounting officer

 






EXHIBIT 32.1


Section 1350 Certification


In connection with the Quarterly Report of Social Reality, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, Christopher Miglino, Chief Executive Officer, and I, Joseph P. Hannan, Chief Financial Officer, of the Company, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

 

2.

The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.


May 15, 2018

 

/s/ Christopher Miglino

Christopher Miglino, Chief Executive Officer, principal executive officer


May 15, 2018

 

/s/ Joseph P. Hannan

Joseph P. Hannan, Chief Financial Officer, principal financial and accounting officer



A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.